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ABSTRACT
Neurons can adjust their ionic currents to maintain a stable output. The homeostatic
mechanisms that produce compensatory changes in ionic currents operate over multiple time
scales. The rapid mechanisms that act over minutes are mostly unknown. We have been
characterizing a fast homeostatic mechanism that stabilizes activity phase in the rhythmically
active lateral pyloric neuron (LP) of the crustacean stomatogastric ganglion. LP activity phase is
invariant. It is determined, in part, by the balance between the hyperpolarization-activated
current (Ih) and the transient potassium current (IA). When LP IA is experimentally decreased,
activity phase is initially disrupted, but then it recovers over minutes. This is because the
decrease in IA modifies LP activity, which in turn alters cytosolic Ca2+ levels. Ca-dependent

enzymes then mediate a reduction in LP Ih to restore the balance between the two conductances.
We have been studying the molecular mechanisms that correlate LP I A and Ih in an activitydependent fashion. We have found that neuronal activity adjusts the level of ion channel posttranslational modification by Small Ubiquitin-like Modifier (SUMO), a peptide which when
conjugated to target proteins alters their protein-protein interactions. Using a heterologous
expression system, we showed that enhancing SUMOylation of HCN or Kv4 ion channels that
mediate Ih and IA, respectively, produced opposite effects on the amplitudes of I h and IA. We also
demonstrated that a given change in activity produced the opposite effect on SUMOylation
levels associated with each current. Thus, activity-dependent regulation of ion channel
SUMOylation specified a positive correlation between the two currents. We have also
demonstrated that activity-dependent regulation of ion channel SUMOylation is conditional; it
only occurs in the presence of the appropriate modulatory tone. We showed this is because
modulators, like dopamine, specify the targets of the SUMOylation machinery. In sum, we have
discovered a novel mechanism that acts over minutes to correlate ionic conductances and thereby
stabilize neuronal output.

INDEX WORDS: SUMOylation, Dopamine, Activity-Dependent, Ion Channel, HCN, Kv4,
Homeostatic Regulation, Stomatogastric
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1

INTRODUCTION

Rhythmically active networks drive such functions as walking, swallowing, breathing,
and swimming. These types of networks require that the precise timing of component neuron
firing remain stable while still being flexible enough to respond to external stimuli. Thus, a
mechanism is needed to stabilize neuronal excitability and maintain activity within a specific
range. In the rhythmically active pyloric network of the spiny lobster, the timing of network
neuron firing (phase) is maintained within a narrow range across individual animals (Bucher,
Prinz et al. 2005, Goaillard, Taylor et al. 2009). Maintenance of pyloric neuron phase has been
attributed to multiple cellular and synaptic parameters including the correlation of specific ionic
conductances (Soofi, Archila et al. 2012, Zhao and Golowasch 2012). Researchers have
described a long-term mechanism that acts through transcription and translation to maintain these
correlations. However, we have published evidence that alterations in phase can be restored over
minutes in the presence of tonic Dopamine (DA) (Krenz, Rodgers et al. 2015), indicating that a
fast activity-dependent mechanism also exists to maintain phase. This dissertation will
investigate a novel role for Small Ubiquitin-like Modifier (SUMO) in the rapid coregulation of
the transient potassium current (IA) and the hyperpolarization-activated current (Ih). We will also
begin to characterize the involvement of tonic DA in the SUMO-mediated activity-dependent
regulation of ionic conductances.
1.1

Stomatogastric Nervous System
The crustacean Stomatogastric Ganglion (STG) is a component of the Stomatogastric

Nervous System (STNS), a well-characterized central pattern generator that drives the rhythmic
contraction of the gut and foregut of the spiny lobster. The STG has long been an ideal model
system for studying motor pattern generation and the effects of neuromodulation on a neural
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circuit. Modulatory input is sent to the STG via descending inputs through the stn (Fig 1.2A;
CoG), as well as being present in the hemolymph that is continuously bathing the ganglion
(Oginsky, Rodgers et al. 2010, Hedrich, Diehl et al. 2011). Our work will focus on the pyloric
circuit of the STG, a 14-neuron recurrent inhibitory circuit that drives the rhythmic contraction
of the foregut (Fig 1.2C). The pyloric circuit produces a triphasic rhythm, that can be observed in
vivo and in situ, through the patterned bursting of six different cell types. Each neuron fires in a
particular phase relative to the other neurons. The firing pattern is set by the electrically coupled
pacemaker kernel, composed of the anterior burster (AB) and the two pyloric dilator (PD)
neurons, which simultaneously inhibit follower neurons (LP, PY, IC, and VD) (Fig 1.2C)
(Marder and Bucher 2007). Through post-inhibitory rebound (PIR) the follower neurons
repolarize and fire a burst of action potentials. The varying rates of PIR together with the
synaptic architecture determine the order and timing of each follower neuron’s burst. The lateral
pyloric (LP) and inferior cardiac (IC) neurons recover first following pacemaker inhibition. Next
the pyloric (PY) and ventricular dilator (VD) neurons fire to complete the triphasic cycle
(Fig1.2B).
The LP neuron will be the primary focus of our research. LP functions in the circuit to
slow increasing cycle frequencies. It sets an upper limit on cycle frequency by inhibiting PD.
The timing of LP inhibition is critical because it maintains the narrow range of frequencies the
network experiences. Without LP feedback on the pacemaker, frequencies could increase outside
of that range and disrupt network activity (Weaver and Hooper 2003). The timing of LP
inhibition is determined by its PIR (Johnson, Brown et al. 2011). The ratio of two opposing ionic
conductances, IA and Ih, regulates the rate of PIR (Harris-Warrick, Coniglio et al. 1995).
Hyperpolarized potentials remove IA inactivation, and activate Ih, depolarizing the cell (He, Chen
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et al. 2014). Upon depolarization IA is activated, producing an inward current that slows
depolarization (Tierney and Harris-Warrick 1992, Birnbaum, Varga et al. 2004). In part, it is the
balance between these two currents, one depolarizing the cell, the other slowing that
depolarization, in part regulate the time at which the neuron fires its burst of action potentials.
The distribution, function, and regulation of IA and Ih have been extensively studied in the
STG. In the pyloric network, IA plays an important role in determining neuron firing phase, cycle
frequency, and spike frequency (Tierney and Harris-Warrick 1992, Harris-Warrick, Coniglio et
al. 1995). The shal channel that mediates IA undergoes extensive alternative splicing with the
biophysical properties of the different spliceforms showing significant variability (Baro, Levini
et al. 1997, Baro, Ayali et al. 2000, Baro, Quinones et al. 2001). Shal channels are primarily
localized to the somatic membrane, primary neurites, and the neuropil of STG neurons (Baro,
Ayali et al. 2000). Ih plays a critical role in neuronal excitability, rhythmic activity, and synaptic
function (Robinson and Siegelbaum 2003, Goeritz, Ouyang et al. 2011, Kase and Imoto 2012).
The Hyperpolarization-activated Cyclic Nucleotide-gated (HCN) channel that mediates Ih in the
STG is also subject to alternative splicing, and the identified spliceforms show large variability
in activation kinetic and voltage dependences (Ouyang, Goeritz et al. 2007). HCN channels
primarily localize to the fine neural in the STG, in close proximity to synapses (Goeritz, Ouyang
et al. 2011). Researchers have overexpressed shal in identified pyloric neurons and observed a
corresponding increase in expression of Ih that prevented any significant changes in network
activity (MacLean, Zhang et al. 2003, MacLean, Zhang et al. 2005). Interestingly, when the
reciprocal experiment was performed, overexpressing Ih did not lead to a corresponding increase
in IA expression (Zhang, Oliva et al. 2003). However, additional studies have also demonstrated
correlated expression of IA and Ih and have underscored its importance in maintaining stable
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network activity (Khorkova and Golowasch 2007, Hudson and Prinz 2010, Temporal, Desai et
al. 2012, Zhao and Golowasch 2012, Golowasch 2014).
Phase refers to the timing of network neuron firing relative to the other network
components. We study LP-on phase, which refers to the timing of LP firing relative to the
pacemaker, and is calculated by dividing the LP-on delay by the cycle period (Fig 1.2B; b÷a)
(Rodgers, Fu et al. 2011). Despite there being several-fold variability in conductance levels and
synaptic strengths across individuals, phase and the IA:Ih ratio are both highly conserved,
underscoring their importance (Bucher, Prinz et al. 2005, Goaillard, Taylor et al. 2009).
Maintaining IA:Ih requires a regulatory mechanism or homeostat (MacLean, Zhang et al. 2003,
MacLean, Zhang et al. 2005), and recent evidence indicates that tonic DA modulation may be
part of that mechanism (Rodgers, Fu et al. 2011, Krenz, Hooper et al. 2013, Krenz, Parker et al.
2015).
1.2

Dopamine
DA is a neuromodulator that plays an essential role in many neurological processes such

as motor control, reward, and motivation. Dysfunction of the dopaminergic system can result in a
variety of conditions including Parkinson’s Disease, Schizophrenia, Restless Leg Syndrome, and
Attention Deficit Disorder (ADHD)(Schultz 2007). DA is released from dopaminergic neurons
through volume transmission in many model systems, including the STNS (Oginsky, Rodgers et
al. 2010). As opposed to a classical synapse where receptors are located within the synaptic cleft,
directly adjacent to where the neuromodulator is being released, DA releases far away from its
receptor and diffuses to reach them or reach distant reuptake mechanisms (Schultz 2007).
Tonically active DA neurons produce a constant presence of DA at nanomolar (nM) levels,
referred to as tonic DA (Schultz 2007, Owesson-White, Roitman et al. 2012, Nirogi, Komarneni
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et al. 2013). Upon stimulation, dopaminergic neurons will release DA in bursts. This produces a
transient increase in DA concentration that can reach micromolar (μM) to millimolar (mM)
levels near the dopaminergic neuron at the time of release, and is referred to as phasic DA
(Justice 1993, Goto, Otani et al. 2007, Rice, Patel et al. 2011). DA receptors can be present in
either a high or low-affinity states. Tonic DA will activate high-affinity receptors, while phasic
DA will activate low-affinity DA receptors, producing different responses in the target neuron.
Tonic DA plays an enabling role and is known to enable motor, cognitive, and motivational
processes (Bilder, Volavka et al. 2004, Krenz, Hooper et al. 2013, Krenz, Rodgers et al. 2015).
On the other hand, phasic DA modifies these processes and many others (Schultz 2007,
Bromberg-Martin, Matsumoto et al. 2010, Lisman, Grace et al. 2011). DA activates either type-1
or type-2 receptors (D1R and D2R respectively). Both receptors couple with G proteins and
activation of these receptors have opposing effects. D1R’s, acting through G s increase adenylyl
cyclase activity while D2R’s acting through G i/o decrease it (Clark and Baro 2006, Clark, Khan
et al. 2008). LP exclusively expresses D1Rs, therefore, the work presented here will focus on the
canonical D1R pathway.
1.3

Dopamine in the STG
In the STG, phasic and tonic DA can affect many aspects of the network including

rhythmic activity, the firing properties of specific neurons, synaptic strengths, and ionic
conductances. Bath applying phasic DA to the STG alters the firing properties of each pyloric
neuron differently (Harris-Warrick, Johnson et al. 1998). Since these early findings, additional
studies have characterized the specific effects of DA on network output, synaptic strengths, and
specific ionic conductances. In a study that examined the effects of phasic DA on the cycle
frequencies of isolated pyloric neurons and the complete pyloric network, they found that phasic
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concentrations of DA slightly decreased the cycle frequency of the pyloric rhythm (Ayali and
Harris-Warrick 1999). This overall decrease in cycle frequency closely resembled the DA
modulated decrease in the isolated AB-2xPD pacemaker kernel, resulting from the combination
of an increase in AB frequency paired with a decrease in the frequencies of both PD neurons.
Researchers have also characterized the pre- and postsynaptic effects of DA modulation at many
of the pyloric synapses. As was mentioned before the synapse between LP and PD is particularly
important because LP directly inhibits the pacemaker and can function to slow the network
rhythm. DA modulation enhances LP pre-synaptic transmitter release through an increase in
calcium levels at the presynaptic terminals and decreases the PD post-synaptic responsiveness to
the transmitter (Johnson, Peck et al. 1995, Cleland and Selverston 1997, Johnson and HarrisWarrick 1997, Johnson, Kloppenburg et al. 2003, Kloppenburg, Zipfel et al. 2007, Johnson,
Brown et al. 2011). The net outcome of these opposing effects is an overall enhancement of the
inhibitory LP/PD synapse. Common among many pyloric neurons is DA modulation of IA and Ih,
although the directionality of this modulation can differ between neuron types. For instance,
phasic concentrations of DA reduce IA in the AB, PY, and IC neurons (Peck, Nakanishi et al.
2001), while it increases IA in the PD neuron (Kloppenburg, Levini et al. 1999). Phasic DA
significantly shifted the voltage of activation in the depolarized direction without changing G max
in LP, AB, PY, and VD neurons, with no effect on PD and IC Ih (Harris-Warrick, Coniglio et al.
1995, Peck, Gaier et al. 2006).
Our work focuses on the mechanisms that regulate LP neuron activity, and bath
application of phasic µM DA decreases LP IA, disrupting the LP IA:Ih ratio and producing an
advance in LP-on phase (Rodgers, Fu et al. 2011). The phase advance is accompanied by an
increase in network cycle frequency and a decrease in LP burst duration. With persistent
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exposure to phasic µM levels of DA, LP phase recovers while cycle frequency and burst duration
remained altered (Rodgers, Fu et al. 2011, Krenz, Hooper et al. 2013). Additional studies have
begun to describe both long and short-term mechanisms that regulate IA and Ih and the role of
tonic DA in this regulation.
To date, studies examining the correlation between Ih and IA have focused long-term
mechanisms that coregulate the two conductances through transcription and translation (Schulz,
Goaillard et al. 2007, Temporal, Desai et al. 2012). We have demonstrated that tonic DA can
regulate both LP IA and Ih over the long-term through transcription and translation. Tonic DA
persistently increases LP IA Gmax through a translation-dependent mechanism (Rodgers, Krenz et
al. 2011, Rodgers, Krenz et al. 2013). We also showed that when LP-on phase is advanced in a
manner that is thought to be mediated by an increase in IA, phase can recover in the presence of
tonic DA over the course of an hour (Rodgers, Fu et al. 2011). When changes in LP Ih were
prevented phase recovery was no longer observed in the presence of tonic DA (Rodgers, Fu et al.
2011, Krenz, Hooper et al. 2013). These findings indicate that tonic DA may stabilize network
activity through translation-dependent long-term regulation of LP IA and Ih, likely to maintain the
previously described IA:Ih.
Although a majority of the literature examining the coregulation of ionic conductances
describes a long-term mechanism acting over hours, logic would dictate that a short-term
mechanism may also exist to restore conductance correlations and maintain stable network
activity rapidly. Our recent findings have begun to describe an activity-dependent mechanism
that can regulate ionic currents over minutes to restore LP-on phase. Rapid recovery of LP-on
phase was demonstrated by pharmacologically decreasing IA, advancing LP-on phase after only
1min (Krenz, Rodgers et al. 2015). LP-on phase recovered after only 20 mins, in the presence but
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not the absence of tonic DA. Additional experiments that prevented changes in LP Ih with Cs
showed that phase was no longer recovered in the presence of tonic (Krenz, Hooper et al. 2013,
Krenz, Rodgers et al. 2015). We found that in fact tonic DA LP Ih Gmax to be bidirectionally
regulated by changes in duty cycle.
In the presence but not the absence of tonic DA (5nM), bidirectional changes in LP duty
cycle (LP burst duration ÷ cycle period) produce corresponding bidirectional changes in LP Ih
Gmax (Krenz, Rodgers et al. 2015). In these experiments, the STG was superfused with saline
containing or lacking (control) 5nM DA and slow wave and spike activity were blocked with
TTX. LP activity, measured before TTX application, was used to construct a voltage step
protocol to mimic the slow wave oscillations of LP. This voltage step protocol was then used to
increase or decrease LP duty cycle and Ih was measured before and 10min after applying the
voltage protocol. When the change in LP Ih Gmax (Ih Gmax after voltage protocol ÷ LP Ih Gmax
before voltage protocol) was plotted against the change in LP duty cycle, we observed that LP Ih
Gmax changed bidirectionally with changes in duty cycle (Krenz, Rodgers et al. 2015). Note that
activity-dependent changes in LP Ih were only observed in the presence of tonic DA and that in
the absence of DA there is no change in LP Ih Gmax regardless of activity.
These experiments were followed by experiments that would begin to uncover the
mechanism mediating LP Ih Gmax activity-dependent regulation (Krenz, Rodgers et al. 2015). We
found that tonic DA acting through D1Rs activates PKA which has two simultaneous effects; 1PKA produces an activity-independent increase in LP Ih Gmax, 2 – PKA permits calcineurin to
decrease LP Ih Gmax in an activity-dependent manner (Krenz, Rodgers et al. 2015). The specific
mechanisms that mediate these processes remain uncharacterized. The work presented here will
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examine SUMO mediated activity-dependent coregulation of LP Ih and IA and the role of tonic
DA in selecting the ionic conductance target of SUMOylation.
1.4

SUMOylation mediates activity-dependent regulation of ion channels
SUMO is a small peptide that is post-translationally added to target proteins, altering the

properties of the modified protein in diverse ways. SUMOylation was first described over 20
years ago for its role in regulating the cell cycle and was thought to be restricted to the nucleus
(Matunis, Coutavas et al. 1996, Mahajan, Delphin et al. 1997). Since then SUMO substrates have
been identified throughout the cell and have been shown to regulate a wide variety of processes
including DNA repair, transcription, protein trafficking, cell migration (Hay 2005). Recent
studies have implicated SUMOylation in the regulation of neuronal proteins with functional
consequences that include the regulation of synaptic plasticity, and altering the biophysical
properties and trafficking of ion channels (Flotho and Melchior 2013).
There are four SUMO homologs in mammals (SUMO1-4). SUMO2 and 3 share ~97%
homology and are often referred to as SUMO2/3 because they are not readily distinguishable by
commercially available antibodies. Despite SUMO1 sharing only ~50% sequence identity with
SUMO2/3 there is significant overlap in target proteins between SUMO1-3. The distribution and
function of SUMO4 remains widely uncharacterized (Henley, Craig et al. 2014). SUMO is
reversibly conjugated to the lysine residue of a target protein through an enzymatic cascade that
closely resembles that of ubiquitin. Precursor SUMO requires proteolytic processing by a
member of the sentrin protease (SENP) family to exposed the C-terminal diglycine motif before
SUMO can be conjugated to a target protein. Mature SUMO is then activated through the
formation of a thioester bond with the E1 SUMO-activating enzyme (SAE1/SAE2) (Fig 1.1).
SUMO is then transferred to the single E2 SUMO-conjugating enzyme (Ubc9), which catalyzes
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the formation of an isopeptide bond between the C-terminal diglycine of SUMO and the lysine
of a target protein (Fig1.1). In some cases, SUMO conjugation by Ubc9 is facilitated by the
presence of an E3 SUMO-ligase (Flotho and Melchior 2013). In most, but not all cases,
SUMOylation occurs at a SUMO consensus sequence, ΨKXE (Ψ is a large hydrophobic residue
and X can be any residue), that can be recognized by Ubc9. Conjugated SUMO can be cleaved
from a target protein by SENP (Fig 1.1). Members of the SENP family of proteases differ in their
affinity for different SUMO homologs as well as their ability to perform both hydrolase
(maturing of precursor SUMO) and isopeptidase (deSUMOylation) functions (Mukhopadhyay
and Dasso 2007, Nayak and Muller 2014).
Once conjugated to a target protein, SUMO acts like a docking station, promoting
interaction between the SUMOylated protein and other proteins that contain a SUMO Interacting
Motif (SIM) domain (Hay 2013). By promoting protein-protein interactions, SUMO can
coordinately regulate functionally related proteins. In neurons, SUMO is emerging as an
important regulator of activity and modulator-dependent processes (Lu, Liu et al. 2009, Loriol,
Khayachi et al. 2013, Loriol, Casse et al. 2014). Numerous reports have described SUMOylation
as being necessary for the regulation of different ion channels, including Na+ channels
(Dustrude, Wilson et al. 2013, Dustrude, Moutal et al. 2016, Plant, Marks et al. 2016), K+
channels (Benson, Li et al. 2007, Dai, Kolic et al. 2009, Plant, Dowdell et al. 2011, Qi, Wang et
al. 2014), and multiple glutamate receptors subunits (O'Brien, Kamboj et al. 1998, Konopacki,
Jaafari et al. 2011, Chamberlain, Gonzalez-Gonzalez et al. 2012, Jaafari, Konopacki et al. 2013,
Choi, Park et al. 2016). SUMO regulation can alter the biophysical properties or trafficking of
ion channels. SUMO-mediated regulation of these channels plays an important role in neuronal
excitability (Dustrude, Wilson et al. 2013, Qi, Wang et al. 2014, Dustrude, Moutal et al. 2016),
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neuronal homeostasis (Craig, Jaafari et al. 2012), LTP (Jaafari, Konopacki et al. 2013, Nair, Patil
et al. 2017), and LTD (Chamberlain, Gonzalez-Gonzalez et al. 2012, Luo, Ashikaga et al. 2013).
SUMO has also been implicated in several neuronal disease states including seizures (Qi, Wang
et al. 2014), Parkinson’s Disease (Eckermann 2013, Guerra de Souza, Prediger et al. 2016),
Alzheimer’s Disease (Lee, Dale et al. 2014, Hoppe, Salbego et al. 2015), Huntington’s Disease
(Ochaba, Monteys et al. 2016), and Down Syndrome (Schorova and Martin 2016). Ion channels
can be regulated by SUMO through either direct modification of the channel or indirect
modification of an interacting protein. For example, direct modification of the Nav1.2 channel
results in a shift of voltage-dependence of activation to a more negative voltage (Plant, Marks et
al. 2016). On the other hand, indirect SUMOylation of CRMP2 promotes CRMP2 interaction
with NaV1.7 leading to an increase in channel externalization (Dustrude, Wilson et al. 2013,
Dustrude, Moutal et al. 2016).
1.5

Hypothesis
The work presented here will seek to address the question, “what are the mechanisms that

mediate fast activity-dependent regulation of correlated ionic conductances?” We hypothesize
that SUMOylation mediates fast activity-dependent regulation of correlated ionic conductances.
We test this hypothesis by first characterizing SUMO regulation of the HCN channel, that
mediates Ih, using a heterologous expression system. Next, we will then look to see if SUMO
mediates activity-dependent regulation of LP Ih Gmax in a similar manner to what was observed in
the heterologous expression system. Finally, we will characterize activity-dependent regulation
of LP IA and the role of SUMO in mediating activity-dependence.
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Figure 1.1 SUMOylation
The SUMO precursor protein is cleaved by SENP to expose its C-terminal diglycine motif (top).
The mature SUMO is then conjugated to the SUMO activating enzyme (E1; SAE1/SAE2)
through the formation of a thioester bond. SUMO is then passed to the SUMO conjugating
enzyme (E2; Ubc9) which can then conjugate SUMO to a target protein through a process that
may be facilitated by the presence of a SUMO ligase (E3). Once conjugated to a target protein
SUMO acts as a docking site for proteins that possess a SIM domain, thus promoting proteinprotein interactions. SUMO can be deconjugated from a target protein by SENP
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Figure 1.2 The Pyloric Network
(A) The STNS is dissected and pinned into a dish. A Vaseline well is used to enclose the STG
(blue box). Saline is continuously superfused through the well (blue arrows). The commissural
ganglia (CoGs) contain DA neurons that project through the stn to the STG. Two of the 14 STG
neurons are depicted here, PD (red) and LP (blue). PD and LP axons project through the dvn and
lvn to reach their target muscles. (B) Extracellular recordings were taken from the lvn and pdn
using pin electrodes. Intracellular recordings were also taken from LP and PD using
micropipettes. LP on-phase is defined as LP on-delay (b) divided by cycle period (a). (C) The
pyloric network: the 6 types of pyloric neurons (open circles) and their connectivity are
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diagrammed. Closed circles represent inhibitory synapses. Red connections show inhibition from
the pacemaker kernel, and resistor/diode connection between AB and PD depicts electrical
coupling
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2
2.1

DETAILED MATERIALS AND METHODS

Hek cells
2.1.1

Tissue Culture

Cells were maintained in EMEM media (Corning; cat#10-009-CV) supplemented with
10% Fetal Bovine Serum (Sigma Aldrich; cat#F6178) and 1% Penecillin Streptomycin (Sigma
Aldrich; cat#P4333) at 37℃ and 5%CO2. For plates that needed to be split and passaged, media
was aspirated and 1-2ml (for 100mm plates) of Trypsin-EDTA 0.25% (Gibco; cat#25200-056)
was added to the plate and incubated for 2-3min, monitoring for cell detachment from the plate.
Using a Pasteur pipette, any cells still attached to the plate were gently washed into one corner of
the dish and the trypsin/cells suspension was transferred to of 15ml tube containing 5ml of
complete media. Cells were gently pelleted at 2,000rpm for 2-3min. The liquid was aspirated
from the cell pellet, the cells were gently resuspended in 1ml of complete media, an appropriate
number of cells were dropped on a plate containing fresh media and gently swirled to distribute
the cells evenly. Plates were returned to the 37℃ and 5%CO2 incubator. If a specific number of
cells needed to be plated a hemocytometer was used to determine a cell count. Briefly,
suspended cells were diluted in 500µl of complete media (1:25), 100µl of Trypan blue was
added, gently mixed and incubated for 5min at room temperature. Cells were then pipetted into
the hemocytometer and counted according to the instructions included with the hemocytometer.

2.1.2

Cryopreservation

For long-term storage of Hek cells, a confluent 100mm plate was trypsinized, cells were
pelleted and resuspended in 1ml of complete media. Hek cell suspension was transferred to a
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cryotube (Thermo Fisher; cat#368632) containing 75ul (7.5%) DMSO, inverted to mix and
quickly placed in a styrofoam box inside of a -80℃ freezer. Once frozen, usually 24hr later, the
cryotube was transferred to a dewar filled with liquid nitrogen.
2.2

Calcium Phosphate Transfection
Approximately 24hr before transfection, enough cells were seeded onto a 60mm culture

dish to obtain ~60% confluence the next day (~1.9x106 cells). The next day, the media was
changed 1hr before transfecting. For a 60mm plate, 25µg total of plasmid DNA (divided equally
for co-transfections) was combined with TE Buffer (10mM Tris-HCl, 1mM EDTA) to obtain a
total volume of 440µl. Next, 60µl of 2M CaCl2 was added drop wise to the DNA mixture, while
gently flicking the tube. Next, 500µl of 2xHBS (275mM NaCl, 10mM KCl, 12mM dextrose,
1.4mM Na2HPO4, 40mM HEPES, pH 7.05-7.10, sterile filtered) that had been slowly thawed at
room temperature was added dropwise while mixing. DNA mixture was immediately added to
the cells by carefully dropping it evenly over the plate and gently rocking the plate to distribute
the DNA. Plates were returned to the incubator for 4hr, and then the media was changed. The
transfection efficiency was checked 48hr later, and only plates with >80% efficiencies were used
for western blotting experiments.
2.3

GFP Immunoprecipitation
2.3.1

Hek Cell Lysates

To obtain a lysate, media was aspirated from a 100mm plate, and the plate was gently
washed twice with cold PBS (137mM NaCl, 2.7mM KCl, 10mM Na2HPO4, 1.8mM KH2PO4, pH
7.4). Cells were lysed by adding 1ml of RIPA Buffer (50mM Tris-HCl pH7.4, 150mM NaCl,
0.1% SDS, 0.5% Deoxycholate, 1% NP-40, 20mM EDTA, 20mM N-Ethylmaleimide, 1:100
protease inhibitor cocktail) to the plate and incubating for 30min on ice, rocking the plate
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occasionally. A cell scraper was used to scrape the contents of the plate into one corner where it
could be collected and transferred to a microcentrifuge tube. Cell debris was pelleted at
14,000rpm at 4℃ for 10min, and the supernatant (cell lysate) was transferred to a clean
microcentrifuge tube. Protein concentration was determined by BCA Assay. Briefly, 25µl of
lysate (diluted 1:1, 1:5, and 1:10) and Bovine Serum Albumin standards (0, 125, 250, 500, 750,
1000, 1500, and 2000µg/ml) were added to the wells of a 96 well plate, noting of the order of the
samples, 200µl of Reagent A:B (50:1) was added to each well, the plate was covered with plastic
wrap and incubated at 37℃ for 30min. The absorbance was measured at 562nm on a plate reader
and used with the standard concentrations to construct an xy-plot that was fit with a linear
trendline. The equation for the trendline was then used to calculate the concentration of the lysate
samples.
2.3.2

Co-Immunoprecipitation

Co-immunoprecipitation experiments of Hek cell lysates were performed using the Pierce
Classic Magnetic IP & Co-IP Kit (Thermo Scientific cat# 88804). For GFP Co-IPs, 1mg of
protein was combined with 2µl of an anti-GFP antibody (Abcam, cat# ab290) in a
microcentrifuge tube with Pierce IP Lysis/Wash Buffer to a total volume of 500µl.
Antibody/antigen complex was incubated together overnight at 4℃ with agitation. Magnetic
beads were prepared by combining 25µl of the beads with 175µl of Pierce IP Lysis/Wash Buffer,
collecting the beads on a magnetic stand, removing the supernatant, and repeating the wash with
an additional 500µl of Pierce IP Lysis/Wash Buffer. The antigen/antibody complex was then
added to the washed beads and incubated for 1hr at room temperature with agitation. The beads
were then collected and washed twice with Pierce IP Lysis/Wash Buffer. To elute the
immunoprecipitated product, 100µl of Elution Buffer was incubated with the beads for 10min at
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room temperature, the beads were then collected, and the eluate was retained and neutralized
with 10µl of Neutralization Buffer.
2.4

Biotinylation
Hek cells on 60mm plates were washed twice with 1ml of cold PBS-CM (PBS - 137mM

NaCl, 2.7mM KCl, 10mM Na2HPO4, 1.8mM KH2PO4, pH 7.4 supplemented with 0.2mM CaCl2
and 1.5mM MgCl2). Biotin was added to the plate (2ml of 1mg/ml in PBS-CM; Thermo Fisher;
cat#21331) and incubated for 30min at 4℃. Cells were washed twice with ice cold PBS-CM, and
then 2ml of Quench Buffer (PBS-CM, 1.5mM MgCl2, 0.2mM CaCl2, 100mM Glycine) was
added to the plate and incubated for 15min at 4℃. Next, the cells were lysed in 500µl RIPA
Buffer (1% NP40, 50mM Tris pH 7.4, 150mM NaCl, 0.1% SDS, 0.5% DOC, 2mM EDTA,
protease inhibitor cocktail at 1:100) for 30min on ice, occasionally rocking the plate. Contents of
the plate were scraped into one corner using a cell scraper (Thermo Fisher; cat#08100241), the
lysate was transferred to 1.5ml microcentrifuge tube, and the cell debris was pelleted by
centrifuging for 10min at 14,000rpm at 4℃. NeutrAvidin beads (Thermo Fisher; cat#29201)
were prepared by adding 100µl of NeutrAvidin slurry to a spin column (Thermo Fisher;
cat#69725) and washing three times with 500µl of PBS, centrifuging for 1min at 500xg between
each wash. The bottom of the spin column was capped, and the cleared lysate was then incubated
with the beads for 2hr at 4℃ with agitation. Columns were uncapped and centrifuged for 2min at
1000xg; flow-through was retained as “intracellular fraction”. Beads were washed 3 times with
500µl of Wash Buffer 1 (PBS supplemented with 1% NP40, and 0.1% SDS), 3 times with 500µl
of Wash Buffer 2 (PBS supplemented with 0.1% NP40 and 0.5M NaCl), and then the tube was
capped and 50µl of SDS Buffer (50mM Tris-HCl pH 6.8, 100mM DTT, 2% SDS, 0.1%
Bromophenol blue, 10% glycerol) was added and incubated for 1hr at room temperature to elute
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extracellular protein. Eluted protein (extracellular fraction) was centrifuged from the column into
a clean tube at 1000xg for 2min.
Intracellular and Extracellular fractions were run together on a western blot, and the blot
was cut just above the 50kDa ladder marker. The portion of the blot containing proteins >50kDa
was dually probed with anti-GFP (Santa Cruz Biotechnology; cat#sc-8334; rabbit polyclonal;
1:2000) and anti-Na/K Pump (Abcam; cat#ab7671; mouse monoclonal; 1:3000) antibodies; with
expected bands corresponding to GFP-HCN2 being ~150-250kDa and Na/K Pump being
~100kDa. The portion of the blot containing proteins <50kDa was probed with an anti-Actin
antibody (Santa-Cruz Biotechnology; cat#sc-1616-R; rabbit polyclonal; 1:2000) to confirm no
intracellular contamination was present in extracellular samples.
2.5

Whole Cell Patch Clamping of Hek Cells
Poly-L-Lysine coated cover slips were prepared as follows: 20mm round glass coverslips

(Fisher Scientific; cat#12-546-2) were sterilized with ethanol and placed in the wells of 8 well
dishes (Thermo Fisher; cat#267062) to air-dry; enough 50µg/ml Poly-L-Lysine (Sigma Aldrich;
cat#P1524; prepared at 1mg/ml and sterile filtered) was added to each well to cover the
coverslips; coverslips were incubated with Poly-L-Lysine for 1hr at 37℃; Poly-L-Lysine was
aspirated; coverslips were washed once with dH 2O; allowed to air-dry and stored at 4℃. For
whole-cell patch clamping, ~7x104 cells were seeded onto each coverslip 24-48hr before
recording. Coverslips containing cells were perfused with extracellular saline (138mM NaCl,
5.6mM KCl, 2.6mM CaCl2, 1.2mM MgCl2, 10mM HEPES, 10mM Glucose, pH 7.4). Fire
polished patch pipettes (Sutter Instruments; cat#B120-69-15; 5-8MΩ) were filled with
intracellular saline (10mM NaCl, 145mM KCl, 1mM MgCl2, 5mM HEPES, pH 7.2) and
connected to the amplifier. To obtain a whole cell patch, a gentle negative pressure was used to
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form a ≥1GΩ seal between the cell membrane and the opening of the micropipette. Suction was
used to rupture the cell membrane and recordings were taken from cells that maintained a seal
≥700 MΩ following rupture. PClamp software implemented voltage protocols that were used to
elicit the current being studied.
2.6

Tat-SUMO Peptide
2.6.1

Tat-SUMO Construct

Activated Panulirus interruptus SUMO (ending in diglycine) cDNA was obtained by
PCR using specific primers that included EcoRI restriction sites on the 5’ and 3’ ends. Briefly,
lobster cDNA was amplified using SUMO Forward (5’-TTTTGAATTCGATGTCCGAGGAAG
CCAAGAA-3’) and SUMO Reverse Primers (5’-GGGGGAATTCTCACCCACCAGTTTGCTG
CTGGAACAC-3’) with the following cycling parameters: 1cycle – 95℃ for 1min; 35℃ cycles
– 95℃ for 30sec, 61℃ for 1min, 68℃ for 1min; 1 cycle – 68℃ for 5min. The ~275bp PCR
product was gel isolated, and both the SUMO cDNA and pcDNA3 Tat HA vector (a gift from
Matija Peterlin (Cujec, Okamoto et al. 1997); Addgene plasmid #14654) were cut with EcoRI
(1ug of DNA to 1U of enzyme). The exposed ends of the cut Tat-HA vector were
dephosphorylated using Calf Intestine Phosphatase (CIP), then the SUMO cDNA and Tat-HA
vector were ligated at a 1:1, insert to vector ratio. The ligation product was transformed into
competent cells, and the presence of colonies containing Tat-SUMO was identified by PCR
using Tat vector-specific primers (For: 5’-GGGGGAATTCTCACCCACCAGTTTGCTGCTGG
AACAC-3’). DNA from colonies containing Tat-SUMO were sequenced to confirm proper
orientation of the insert.
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2.6.2

Tat-SUMO Peptide Synthesis

To synthesize the Tat-SUMO peptide, the plasmid was transformed into BL21CodonPlus (DE3)-RIPL E. coli (Agilent; cat#230280) and plated on NYZ agar plates. A single
isolated colony was grown overnight in 200ml of NYZ broth containing ampicillin (100µg/ml) at
37◦C with agitation. The 200ml overnight culture was then added to 1L of broth containing
500µM IPTG to induce expression of the peptide, and further incubated for 5hr. Cells were
divided among 250ml autoclaved bottles and pelleted at 8,000rmp for 10min at 4 ◦C, and the
pellet was washed with cold PBS (137mM NaCl, 2.7mM KCl, 10mM Na2HPO4, 1.8mM
KH2PO4, pH7.4). Pelleted cells were resuspended in 20ml of Buffer Z (8M Urea, 100mM NaCl,
20mM HEPES, pH8), transferred to autoclaved 50ml centrifuge tubes and sonicated on ice using
a 10sec “on” 30sec “off” protocol at 15% amplitude for a total of 10min. Sonicate was cleared by
centrifuging at 12,000rpm for 10mins at 4◦C. The supernatant was transferred to a clean tube and
the cleared sonicate was equilibrated with 10mM imidazole. Next, 10ml of Ni-NTA agarose
resin (Qiagen; cat#1018244) was equilibrated with Buffer Z containing 10mM imidazole and
then incubated with the sonicate at 4◦C for 1hr. The resin mixture was added to a
chromatography column (Bio-Rad; cat#7372512) and washed with 100ml of Buffer Z with
10mM imidazole. The peptide was eluted with incrementally increasing concentrations of
imidazole (100, 250, 500mM, and 1M; 10ml each) and the buffer was exchanged for PBS with
10% glycerol using PD-10 desalting columns (GE Healthcare; cat#17085101). Peptide
concentration was determined by BCA assay (as described in 2.5.1).
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CHAPTER 1: SUMOYLATION OF THE HYPERPOLARIZATION-ACTIVATED
CYCLIC NUCLEOTIDE-GATED CHANNEL 2 INCREASES SURFACE
EXPRESSION AND THE MAXIMAL CONDUCTANCE OF THE
HYPERPOLARIZATION-ACTIVATED CURRENT

Publication: Parker, A. R., M. A. Welch, L. A. Forster, S. M. Tasneem, J. A. Dubhashi and D. J.
Baro (2016). "SUMOylation of the Hyperpolarization-Activated Cyclic Nucleotide-Gated
Channel 2 Increases Surface Expression and the Maximal Conductance of the HyperpolarizationActivated Current." Front Mol Neurosci 9: 168.
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3.1

Abstract
SUMO is a ~10kDa peptide that can be post-translationally added to a lysine (K) on a

target protein to facilitate protein-protein interactions. Recent studies have found that
SUMOylation can be regulated in an activity-dependent manner and that ion channel
SUMOylation can alter the biophysical properties and surface expression of the channel. HCN
channel surface expression can be regulated in an activity-dependent manner through unknown
processes. We hypothesized that SUMOylation might influence the surface expression of HCN2
channels. In this manuscript, we show that HCN2 channels are SUMOylated in the mouse brain.
Baseline levels of SUMOylation were also observed for a GFP-tagged HCN2 channel stably
expressed in Hek cells. Elevating GFP-HCN2 channel SUMOylation above baseline in Hek cells
led to an increase in surface expression that augmented Ih, mediated by these channels. Increased
SUMOylation did not alter Ih voltage-dependence or kinetics of activation. There are five
predicted intracellular SUMOylation sites on HCN2. Site-directed mutagenesis indicated that
more than one K on the GFP-HCN2 channel was SUMOylated. Enhancing SUMOylation at one
of the five predicted sites, K669, led to the increase in surface expression and I h Gmax. The role of
SUMOylation at additional sites is currently unknown. The SUMOylation site at K669 is also
conserved in HCN1 channels. Aberrant SUMOylation has been linked to neurological diseases
that also display alterations in HCN1 and HCN2 channel expression, such as seizures and
Parkinson’s Disease. This work is the first report that HCN channels can be SUMOylated and
that this can regulate surface expression and Ih.
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3.2

Introduction
Post-translational modifications can rapidly regulate proteins. SUMOylation is one such

modification that is essential for most organisms (Flotho and Melchior 2013). SUMO (a.k.a.
Sentrin) is a ~100 amino acid peptide that is covalently added to a lysine (K) residue on a target
protein. The addition involves several steps. First, the immature SUMO protein is cleaved by a
SENP, exposing a C-terminal diglycine (Mukhopadhyay and Dasso 2007). The SUMO E1
activating enzyme then transfers the mature SUMO peptide to the E2 conjugating enzyme, Ubc9,
which will then add SUMO to the target protein (Desterro, Thomson et al. 1997). SUMO can
also be deconjugated from a target protein by SENP (Hickey, Wilson et al. 2012). In mammals,
SUMO is encoded by a family of four genes, termed SUMO1-4 (Flotho and Melchior 2013).
SUMO2 and SUMO3 proteins are ~97% identical and are not readily distinguishable in most
experiments. SUMO 1 and SUMO2/3 proteins share ~46% identity, and their sets of targets
greatly overlap. SUMO4 cannot be cleaved into the mature form by Ubc9, and its function is
unclear.
Modification by SUMO is subject to numerous forms of regulation. The
availability of the SUMOylation site on a target protein can be regulated by the presence of other
post-translational modifications. For example, phosphorylation near the SUMOylation site can
either inhibit or enhance SUMOylation (Bossis and Melchior 2006, Konopacki, Jaafari et al.
2011). SUMOylation can also be regulated by the availability of SUMO and/or SUMOylation
enzymes (Loriol, Khayachi et al. 2013).
SUMOylation mediates protein-protein interactions (Makhnevych, Sydorskyy et
al. 2009, Flotho and Melchior 2013). As such, SUMO can coordinately regulate many diverse
cellular processes ranging from DNA repair in the nucleus to signal transduction at the plasma
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membrane (Hickey, Wilson et al. 2012). The effects of SUMO are observed throughout the
neuron (Henley, Craig et al. 2014). SUMOylation can influence neuronal transcription by
controlling the stability of transcription factors; for example, BMAL1 ubiquitination and
degradation is enhanced when it is SUMOylated (Lee, Lee et al. 2008). SUMO can also regulate
synaptic release. SUMOylation of the synaptic vesicle protein, RIM1α, promotes its direct
interaction with Cav2.1 channels, causing them to form clusters, which leads to rapid exocytosis
of synaptic vesicles (Girach, Craig et al. 2013). In addition, SUMOylation plays a role in the
trafficking of integral membrane proteins such as kainate receptors. SUMOylation of GluK2 is
required for agonist-induced internalization of the kainate receptor, likely by facilitating its
interaction with scaffolding and/or trafficking proteins (Konopacki, Jaafari et al. 2011,
Chamberlain, Gonzalez-Gonzalez et al. 2012). However, the distinct interaction that leads to
GluK2 internalization is still unknown. Voltage-gated ion channels are fundamental constituents
of the neuronal membrane. Their trafficking is complex and highly regulated. The functions of
SUMOylation in voltage-gated ion channel trafficking are largely unknown. We are interested in
the role of SUMOylation in the regulated trafficking of Hyperpolarization-activated Cyclic
Nucleotide gated (HCN) ion channels.
HCN channels play a pivotal role in shaping neuronal excitability and synaptic
integration by influencing several neuronal activity features including membrane potential, firing
threshold, resonance frequency, temporal summation and synaptic strength (Hutcheon and
Yarom 2000, Wahl-Schott and Biel 2009, Shah 2014). The mammalian HCN1-4 gene family
encodes distinct channel isoforms (He, Chen et al. 2014). All isoforms are permeable to K+ and
Na+, activate upon hyperpolarization, and mediate a slowly depolarizing current termed the
hyperpolarization-activated current (Ih). Besides being activated at hyperpolarized potentials,
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HCN channels can also be gated by the binding of cyclic nucleotides to the C-terminal CNBD
found in all isoforms (Robinson and Siegelbaum 2003, He, Chen et al. 2014).
HCN isoforms differ in their biophysical properties and modulation by cAMP. Under
basal conditions, the CNBD inhibits hyperpolarization-gating to a different extent in each
isoform due to its isoform-specific interactions with the core transmembrane domain and the Clinker that connects the CNBD to the transmembrane domain (Wang, Chen et al. 2001). This
variable inhibition results in isoform-specific steady-state activation curves. For example, the
steady-state activation curve of HCN2 channels is 20mV more hyperpolarized compared with
HCN1 channels. Binding of cAMP to the CNBD relieves its inhibition on hyperpolarizationgating. Because of the isoform-specific interactions between the CNBD and the C-linker, the
effect of cAMP binding will vary with the isoform (Wang, Chen et al. 2001). For example,
binding of cAMP to the CNBD of HCN2 and HCN1 channels shifts their respective activation
curves to more positive potentials, but HCN2 channels display a 17mV shift while HCN1
channels display a 4mV shift. Maximal effects of cAMP binding are observed for HCN2 and
HCN4 isoforms. The activation kinetics also varies between isoforms with HCN1 and HCN4
having the fastest and slowest activation kinetics, respectively.
In addition to their distinct biophysical properties and cAMP modulation, each of the four
isoforms also displays a unique expression pattern in the nervous system (He, Chen et al. 2014).
HCN1 is highly enriched in the neocortex, hippocampus, cerebellar cortex and brainstem. HCN2
is widely expressed in most brain regions, while HCN3 has low expression levels in the nervous
system. HCN4 expression mirrors HCN1 and is also selectively expressed in several thalamic
nuclei and neuronal populations in the basal ganglia and habenular cortex. The formation of
heteromeric channels further enhances the complexity of I h function and modulation in vivo.
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HCN channel surface expression throughout the nervous system can be adjusted over
several time courses (Zha, Brewster et al. 2008, Shah 2014, Furst and D'Avanzo 2015, Smith, Al
Otaibi et al. 2015, Brennan, Baram et al. 2016). Regulated SUMOylation could play a role in the
trafficking of HCN channels. Since the trafficking of HCN2 channels has been fairly well
studied (see Discussion), here we examine SUMOylation of HCN2 channels.
3.3

Methods
3.3.1

Drugs

All drugs were obtained from Sigma-Aldrich with the exception of Tween 20 (Fisher
Scientific).
3.3.2

Mouse Brain Membrane Preparations

Nondenaturing: A single mouse forebrain was homogenized on ice in homogenization
buffer (5mM NaH2PO4 buffer, 0.32M sucrose) supplemented with protease inhibitor cocktail
(1:100, Sigma cat. #P8340) and 20mM N-Ethylmaleimide (NEM) to prevent SUMO
deconjugation (Suzuki, Ichiyama et al. 1999). Cell debris was pelleted at 5,000rpm for 10min at
4°C, and the supernatant was retained and further centrifuged at 40,000rpm for 90min at 4°C to
pellet membrane-bound proteins. The supernatant was removed and the pellet containing
intracellular and extracellular membrane bound proteins was resuspended in 1ml of resuspension
buffer (0.5% SDS, 5nM NaH2PO4, protease inhibitor cocktail at 1:100) followed by shaking at
4°C for 1hr. Denaturing: Tissue homogenization and centrifugation were the same as for the
nondenaturing preparation. The membrane pellet was resuspended in 100µl of denaturing buffer
(2% SDS, 50mM Tris-HCl pH7.5, 5mM DTT) followed by shaking at 4°C for 1hr. The
preparation was then diluted to 1ml total volume with dH2O and boiled for 10min. In all cases
protein concentration was determined with a bicinchoninic acid assay (BCA Assay, Pierce BCA
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Protein Assay Kit). Mouse brain membrane fractions were obtained from whole mouse forebrain
tissue generously provided by Dr. Chun Jiang. All animal procedures were conducted in
compliance with the regulation of the Institutional Animal Care and Use Committee of Georgia
State University.
3.3.3

Plasmids and Antibodies

A previously described mouse GFP-HCN2 fusion plasmid (Santoro, Wainger et al. 2004)
was generously provided by Dr. Bina Santoro’s Lab. Plasmids for transient transfection include
the following: mCherry2-C1 was a gift from Michael Davidson (Addgene plasmid #54563),
Ubc9 (Yasugi and Howley 1996) was a gift from Peter Howley (Addgene plasmid #14438),
SENP1 (Cheng, Kang et al. 2007) was a gift from Edward Yeh (Addgene plasmid #17357), and
SUMO2 (Kamitani, Nguyen et al. 1998) was a gift from Edward Yeh (Addgene plasmid
#17360). Antibodies used are shown in Table 1, and the specificity of each antibody was verified
as indicated in the table.
3.3.4

Site Directed Mutagenesis

PCR was used to create two site-directed mutations in the GFP-HCN2 fusion plasmid
described above: K534R and K669R. The two sets of primers are listed in Table 2. PrimeStar
GXL polymerase (Takara) was used along with the buffer, nucleotides, and instructions supplied
by the manufacturer. Typically, 10ng of plasmid DNA served as the template in a 50μl reaction.
The cycling conditions were: 1x 98°C,1min; 30x 98°C,30sec, 68°C, 7min; 1x 68°C, 5min. Upon
completion, 20 units of DpnI (Clontech) were added to the reaction, which was incubated at
37°C for 1-2hr to digest the template DNA. Afterward, 1-2μl of the reaction was added to a 50μl
aliquot of subcloning grade competent XL1blue cells (Agilent) and incubated on ice for 30min.
The cells were then heat-shocked at 42°C for 45sec. NZY broth (100μl) was added, and the cells
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were incubated at 37°C for 20min to allow for expression of kanamycin resistance. Cells were
then plated on NZY plates containing 30μg/ml kanamycin and incubated at 37°C overnight.
Plasmid DNA from resultant colonies was isolated (Qiagen), the insert was sequenced in its
entirety, and analyzed with Lasergene software (DNAstar) to ensure that only the intended
mutation was generated. All sequencing was done by the Georgia State University Cell Protein
and DNA Core Facilities. To create multiple mutations, a previously mutated GFP-HCN2 fusion
plasmid was used as the template for a PCR with a different primer.
3.3.5

Cell culture, Stable and Transient Transfections

Hek-293 cells and all cell culture reagents were obtained from American Type Culture
Collection (ATCC; Manassas, VA). Hek-293 cells were cultured at 37°C, and 5% CO2 in EMEM
media supplemented with 10% fetal bovine serum and 1% Penicillin-Streptomycin.
Transfections to produce stable lines: A cell line stably expressing a GFP-HCN2 fusion protein
(Hek-HCN2) was generated by transfecting a 60mm plate of Hek-293 cells with the GFP-HCN2
plasmid using Lipofectamine 2000 (Invitrogen) according to instructions provided by the
manufacturer. After two days, transfected cells were trypsinized, resuspended and replated to
60mm plates (5-20l of a 1ml cell resuspension per 60mm plate) and the selection agent, G418
(Geneticin, Gibco, 500µg/ml), was added to the media. After 3-5 weeks, individual colonies
were selected using cloning rings. Stable expression was checked by fluorescence and whole cell
patch clamping for Ih. In all cases, a colony was selected only if GFP and Ih was observed in
every cell; however, the intensity of GFP expression and Ih maximal conductance could vary
between colonies from the same transfection by a factor of 10, presumably due to differences in
the number of copies of plasmid integrated into the host cell genome. Stable cell lines expressing
mutant versions of GFP-HCN2 were generated in a similar fashion. Transient transfections: In
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our hands, Lipofectamine transfection efficiencies ranged from 5-25%. This was not adequate for
transient transfection experiments, which required 80-100% transfection efficiency. Therefore, a
high efficiency calcium phosphate transfection was employed for immunoprecipitation,
biotinylation and patch clamping experiments using transient transfection to increase or decrease
SUMOylation. Briefly, cells were plated at ~60% confluence on 100mm or 60mm cell culture
dishes 24hr before transfection. The media was changed at least 1hr before transfection. For a
single 100mm or 60mm dish, 25µg or 10µg of total plasmid DNA, respectively, was diluted in
TE buffer (10mM Tris-HCl pH8, 1mM EDTA), 2M CaCl2 was added dropwise to the DNA
followed by the addition of 2x HBS (275mM NaCl, 10mM KCl, 12mM Dextrose, 1.4mM
Na2HPO4, 40mM HEPES, pH 7.1). Calcium Phosphate/DNA precipitate was then immediately
dropped onto cells. Cells were returned to 37°C and 5% CO2 for 4hr followed by either a media
change or passaging to 20mm Poly-L-Lysine coated coverslips and allowed to grow another 2448hr. Cells were transfected with plasmid DNA expressing either mCherry or a mixture of
mCherry+SUMO+Ubc9 or mCherry+SENP1. For co-transfection of multiple plasmids, the total
amount of plasmid DNA remained the same (25µg or 10µg) but comprised equal amounts of
each of the different plasmids (1:1:1 or 1:1). Transfection efficiency was determined to be the
percentage of cells expressing mCherry as judged by fluorescence microscopy. The transfection
efficiency of every plate was checked for each experiment, and a plate was only used if the
transfection efficiency exceeded 80%.
3.3.6

Immunoprecipitations

GFP-HCN2 IP from Hek cells: 100mm plates containing Hek cells were washed twice
with ice-cold PBS (137mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4)
followed by the addition of RIPA buffer (1% NP40, 50mM Tris pH 7.4, 150mM NaCl, 0.1%
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SDS, 0.5% DOC, 20mM EDTA, protease inhibitor cocktail at 1:100 and 20mM NEM) to the
plate. Cells were lysed on the plate for 30min on ice, rocking occasionally. A disposable cell
scraper was used to scrape any remaining cell debris from the bottom of the plate, and the lysate
was collected and transferred to a sterile tube. Cell debris was pelleted at 12,000rpm for 10min at
4°C, and the supernatant was retained. Protein concentration was determined with a BCA assay.
Immunoprecipitations (IP) were performed using the Classic Magnetic Co-IP Kit (Pierce),
following the manufacturer’s instructions. Typically 1mg of protein was added to the beads and
the protein was eluted from the beads in a volume of 100µl. HCN2 IP from mouse forebrain:
1.5mg of the mouse membrane preparation with 5ug of anti-HCN2 antibody (Table 1) or IgG
(Santa Cruz Biotechnology; sc-2028) were used in combination with the Classic Magnetic Co-IP
Kit (Pierce), following the manufacturer’s instructions. Protein was eluted from the beads in a
volume of 100µl and 20µl was used for one lane of an SDS-PAGE gel.
3.3.7

Western Blotting

Protein samples were run on an SDS-PAGE gel and transferred to a PDVF membrane
using a semidry electroblotting system. A membrane was blocked for 1hr in a solution of 5%
non-fat powdered milk in TBS (10mM Tris-HCl pH7.5, 150mM NaCl), washed for 10min in
TTBS (1x TBS, 0.1% Tween 20), and then incubated overnight at 4°C with the primary
antibody, diluted as described in Table 1, in 1% non-fat powdered milk in TTBS. The membrane
was then washed 3x 5min each in TTBS and then incubated with the appropriate alkaline
phosphatase conjugated secondary antibody, diluted in 1% non-fat powdered milk in TTBS for
2hr at room temperature. Following incubation with the secondary antibody, the membrane was
washed 3x 10min each and Immunstar AP substrate (BioRad) was added to the surface of the
membrane, incubated 5min and then exposed to X-ray film to detect chemiluminescent signals.
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In some cases, membranes were stripped and reprobed. Stripping involved washing the blot 2x
5min each in mild stripping buffer (200 mM Glycine, 0.1% SDS, 1% (v/v) Tween 20, pH 2.2).
The blot was then washed 2x 10min each in PBS and 2x 5min each in TTBS. The blot was then
exposed to film to ensure the signal was removed.
3.3.8

Patch Clamping Electrophysiology

Coverslips (20mm) were dipped in ethanol, allowed to air dry, and incubated with PolyL- Lysine (50µg/ml in dH2O) at 37°C for 1hr. Coverslips were then washed once with sterile
dH2O, air dried, and stored at 4°C. For an experiment, coverslips were seeded with 8x104 cells,
and the next day coverslips containing transiently transfected cells were placed into a chamber
and constantly perfused with extracellular saline solution (138mM NaCl, 5.6mM KCl, 2.6mM
CaCl2, 1.2mM MgCl2, 10mM HEPES, 10mM Glucose, pH 7.4). Cells were visualized on an
Olympus IX70 microscope and transiently transfected cells were identified by fluorescence and
only those expressing mCherry were used for whole cell patch clamping experiments. A firepolished micropipette (Sutter Instruments, 6-8 MΩ) was filled with intracellular solution (10mM
NaCl, 145mM KCl, 1mM MgCl2, 5mM HEPES, pH 7.2) and connected to an Axopatch 200B
amplifier (Molecular Devices, Foster City, CA). To obtain a whole cell patch, a gentle negative
pressure was used to form a ≥1GΩ seal between the cell membrane and the opening of the
micropipette. Suction was used to rupture the cell membrane and recordings were taken from
cells that maintained a seal ≥700 MΩ following rupture. Cells were held at -50mV using pClamp
10 software and Ih was elicited using 5 sec hyperpolarizing voltage steps from -50mV to -120mV
in 10mV increments with 4 seconds between each step. Steady-state peak current was measured
by subtracting the initial fast leak current from the slowly activating Ih for each hyperpolarizing
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voltage step. Conductance was calculated using the peak current at each voltage step (G=
Ipeak/(V m-Vrev); Vrev Ih= -35mV) and fitted to a first order Boltzmann equation.
3.3.9

Cell Surface Biotinylation

Hek-HCN2 cells plated on 60mm culture dishes were transiently transfected with either
mCherry alone (control) or mCherry+SUMO+Ubc9. Cells were washed twice with ice-cold PBS,
supplemented with 0.2mM CaCl2 and 1.5mM MgCl2 (PBS-CM) and incubated for 30min at 4°C
with 0.5-1mg/ml of EZ-link Sulfo-NHS-SS-Biotin (Thermo Fisher, cat#21331). Cells were
washed twice with ice cold PBS-CM, and residual biotin was quenched with PBS-CM plus
100mM glycine for 15min at 4°C. Cells were washed once more with PBS-CM followed by lysis
with ice cold RIPA buffer (1% NP40, 50mM Tris pH 7.4, 150mM NaCl, 0.1% SDS, 0.5% DOC,
2mM EDTA, protease inhibitor cocktail at 1:100) for 30min on ice. A disposable cell scraper
was used to remove any residual cell debris from the bottom of the plate, and the contents were
transferred to a microcentrifuge tube. Cell debris was pelleted by centrifugation at 12,000 rpm
for 10min. The supernatant was removed and immediately incubated for 2hr at 4°C with
Neutravidin agarose resin (Pierce, cat #29201) with agitation. The lysate/resin mixture was
centrifuged in a spin column (Thermo Fisher, cat #69725) at 1000xg for 2min. The flow through
containing unbiotinylated intracellular proteins was retained for western blot analysis. The resin
was washed three times in PBS supplemented with 1% NP40, and 0.1% SDS and three times in
PBS supplemented with 0.1% NP40 and 0.5M NaCl, centrifuging at 500xg for 1min between
each wash. Columns were capped, and biotinylated proteins were eluted from the beads by
incubating for 1hr at room temperature with SDS loading buffer (50mM Tris-HCL pH 6.8,
100mM DTT, 2% SDS, 0.1% Bromophenol blue, 10% glycerol). Columns were uncapped and
centrifuged at 1000xg for 2min to collect the eluted extracellular proteins. Intracellular and
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extracellular fractions were run on an SDS-PAGE gel and transferred to a PVDF membrane. The
membrane was cut at ~50 kDa. The lower portion of the blot was probed with an anti-actin
antibody (Santa Cruz Biotechnology) to confirm that there was no intracellular contamination in
the extracellular samples. The top portion of the blot was dually probed with an anti-GFP
antibody to detect the GFP-HCN2 channel, and an anti-Na+/K+-ATPase antibody to use for
normalization (Table1). To confirm that expression of the Na+/K+-ATPase was not varying
across treatment groups, samples from control and SUMO+Ubc9 transfected cells were run on a
western blot. The blot was stained for total protein (SYPRO Ruby blot stain, Bio-Rad) and then
probed for the Na+/K+-ATPase. The Na+/K+-ATPase signal was normalized by the total protein
in the lane. A comparison of the normalized Na+/K+-ATPase signal across treatment groups
indicated that there were no significant differences between control and SUMO+Ubc9
transfected groups (Student’s t-test, p> 0.05, n=5).
3.3.10 Image analysis and Quantification
ImageJ was used to quantify signals from western blots. Optical density (OD) was
measured using the Gel Analysis feature of the ImageJ software. Briefly, a rectangular box was
drawn around the signal, and ImageJ software was then used to generate a profile plot of the
relative intensity. A line was drawn to isolate the area under the curve and set the baseline,
thereby subtracting the background, and the area under the curve was measured. In order to
ensure images were not saturated, a series of exposures ranging from underexposed to
overexposed was always obtained, and only intermediate exposures were quantified. Quantifying
the fraction of SUMOylated GFP-HCN2 channels in Hek cells involved measuring a SUMO
signal (entire GFP-HCN2 doublet) followed by stripping and reprobing the membrane to obtain a
GFP signal (entire GFP-HCN2 doublet). In order to ensure that differences between treatment
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groups were not due to differences created by stripping or variability in the length of SUMO
relative to GFP film exposure, a complete set of treatment groups was present on each blot, and
measures for each treatment group were obtained from the same exposure/film. However,
variability within a treatment group could be due to stripping and/or relative lengths of
exposures. At best, these experiments are semi-quantitative and the fraction of SUMOylated
channels in these cell lines may be over/under-reported with this method. Nevertheless, they
suffice for detecting significant differences between treatment groups.
3.3.11 Statistical analysis
All data were analyzed using Prism 7 (Graphpad Software Inc.). Each data set was
checked for normality and homogeneity of variance. Data were then analyzed using parametric
statistical tests, including Student’s t-test and One-way ANOVA’s. In all cases, the significance
threshold was set at p<0.05. Values that were greater than two standard deviations from the mean
were considered statistical outliers and were excluded from the data set. ANOVA’s were
followed by post hoc tests that either compared all groups to each other (Tukey’s) or to the
control (Dunnett’s). Unless otherwise stated all values are presented as the mean ± SEM.
3.4

Results
3.4.1

Mouse HCN2 is SUMOylated In vivo

To determine if the mouse HCN2 channel was SUMOylated in vivo, an antibody against
HCN2 (Table 3.1) or IgG (negative control) was used to IP the channel from mouse forebrain
membrane preparations that were or were not denatured, followed by western blot analyses using
antibodies against HCN2, SUMO1 and SUMO2/3. Note that our anti-SUMO2/3 antibody does
not discriminate between SUMO2 vs. SUMO3; therefore, the post-translational modification is
referred to as SUMO2/3. Fig 3.1 illustrates that HCN2 channels were post-translationally
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modified by both SUMO1 and SUMO2/3 in the mouse forebrain. Two bands at ~120 and 75 kDa
were observed in the experimental preparations but not in the negative controls. The band at
~120 kDa was previously identified as the HCN2 channel in mouse membrane preparations
(Much, Wahl-Schott et al. 2003). It was observed in blots probed with anti-HCN2, anti-SUMO1
and anti-SUMO2/3 in both non-denaturing and denaturing IP experiments, which suggests both
SUMO1 and SUMO2/3 are covalently attached to HCN2 channels in the mouse forebrain. The
~75kDa band was detected by the anti-SUMO antibodies, but not by the anti-HCN2 antibody, on
the western blots containing IP experiments using nondenatured membrane preparations. Since
this ~75 kDa band was not observed for the denaturing IP experiments, it most likely represents
an unknown SUMOylated protein that noncovalently associates with HCN2 channels in the
mouse forebrain.
3.4.2

GFP-HCN2 Channels are SUMOylated in a Heterologous Expression System

Previous work suggested that SUMOylation could be manipulated in tissue culture
systems. We therefore generated a Hek-293 cell line stably expressing a GFP-HCN2 fusion
protein (Hek-HCN2) as described in Materials and Methods. Note that GFP is at the N-terminus
of the HCN channel. IP experiments were performed on parental Hek and Hek-HCN2 cell
lysates using an anti-GFP antibody followed by western blot analyses with anti-GFP or antiHCN2 antibodies (Fig 3.2). Both the anti-GFP and the anti-HCN2 antibodies detected the same
two bands between 150 and 250 kDa (Fig 3.2A). This doublet was not observed in the parental
Hek cell line (Fig 3.2B). Together these data suggested that the doublet represented the GFPHCN2 channel. Previous studies on HCN2 channels expressed in Hek cells showed that the
doublet represented two forms of the HCN2 channel (Much, Wahl-Schott et al. 2003, Akhavan,
Atanasiu et al. 2005, Nazzari, Angoli et al. 2008). The slower migrating band contained a
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complex N-glycosylation. The faster migrating band instead possessed a simple or no
glycosylation. Complex N-glycosylation increased the efficiency of surface expression, but
channels possessing only a subset of complex N-glycosylated subunits (Akhavan, Atanasiu et al.
2005) or no complex N-glycosylated subunits (Nazzari, Angoli et al. 2008) could still be
detected at the plasma membrane. Relative to past studies, the doublet detected in our
experiments is larger, presumably due to the GFP tag.
To determine if GFP-HCN2 channels were SUMOylated in our culture system, we
performed the same anti-GFP IP with Hek-HCN2 cell lysates, followed by western blot analyses
using anti-GFP (Fig 3.3, panel 1) and anti-SUMO2/3 (Fig 3.3, panel 2) antibodies. The data
indicated that both antibodies recognized the same doublet between 150-250 kDa, suggesting
that GFP-HCN2 channels were SUMOylated in Hek-HCN2 cells (here termed baseline
SUMOylation). The SUMO signal was not due to similarly sized endogenous Hek proteins
associating with GFP-HCN2 channels because the anti-SUMO2/3 antibody did not detect the
doublet on western blots containing parental Hek cell lysates (Fig 3.3, panel 3).
3.4.3

Transient Transfection of SUMO2 and Ubc9 Increases HCN2 Channel

SUMOylation in a Hek Cell Line Stably Expressing Mouse HCN2
We next wished to manipulate GFP-HCN2 channel SUMOylation in order to study its
function. The conjugating enzyme, Ubc9, adds SUMO to a target protein. In some cases, Ubc9 is
directed to a SUMOylation site by an external factor, such as a SIM domain or an E3 protein
(Flotho and Melchior 2013). In other cases, Ubc9 directly recognizes a consensus sequence and
adds SUMO to the K in the consensus sequence. Oftentimes the latter mechanism requires
additional stabilizing interactions provided by other proteins or post-translational modifications;
however, simply increasing the concentration of the Ubc9 enzyme can obviate their need at some
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(but not all) consensus sequences, and previous work has demonstrated that SUMOylation of
some target proteins can be increased in cell culture by overexpressing SUMO and Ubc9 (Dai,
Kolic et al. 2009). Moreover, SENP has been shown to decrease SUMOylation of some proteins
in a heterologous expression system (Dai, Kolic et al. 2009, Dustrude, Wilson et al. 2013)
despite the fact that SENP has opposing functions: endopeptidase activity removes C-terminal
amino acids to activate SUMO and promote target protein SUMOylation; isopeptidase activity
removes SUMO conjugated to target proteins to promote deSUMOylation (Yeh 2009).
In order to investigate whether or not we could manipulate SUMOylation of GFP-HCN2,
the Hek-HCN2 cell line was transiently transfected with plasmids expressing mCherry, SUMO2,
and Ubc9 or mCherry and SENP1. Control preparations were transfected with mCherry alone.
To determine the fraction of HCN2 channels that were SUMOylated in each treatment group,
GFP-HCN2 channels were immunoprecipitated from lysates using an anti-GFP antibody.
Western blots containing the IP products were first probed with an anti-SUMO2/3 antibody.
Chemiluminescence was used to detect the SUMO signal, and the optical density (OD) for the
entire GFP-HCN2 doublet was measured with ImageJ (see Materials and Methods). After
recording the SUMO signal, the antibody was stripped, and the same blot was reprobed with an
anti-GFP antibody. Again, chemiluminescence was used to detect the GFP signal, and the optical
density (OD) of the entire GFP-HCN2 doublet was measured. The fraction of SUMOylated
channels was defined as the OD of the SUMO signal divided by the OD of the GFP signal (Fig
3.4A). This non-linear, semi-quantitative method indicated that GFP-HCN2 SUMOylation was
significantly increased in the SUMO+Ubc9 group, by an average of 50.7±16.01% relative to the
control (Fig 3.4B). There was no significant difference in the amount of SUMOylated channels
in cells transfected with SENP1 relative to control. This might suggest a low level of baseline
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HCN2 SUMOylation in the Hek-HCN2 cell line. On the other hand, since SENP has two
opposing functions it is also possible that the balance of these two functions doesn’t change upon
SENP1 overexpression, leaving baseline SUMOylation unaltered. In sum, transient transfection
of SUMO and Ubc9 increases HCN2 SUMOylation in Hek-HCN2 cells.
3.4.4

HCN2 Channel SUMOylation Increases Ih Gmax

Hyperpolarization of Hek-HCN2 cells to -120mV consistently elicited an average peak Ih
of 710pA. This current was never detected in the parental Hek cell line (n>10); thus, it is
mediated by GFP-HCN2 channels. We examined if/how SUMOylation affected Ih using whole
cell patch clamp recordings on Hek-HCN2 cell lines that were transiently transfected with
mCherry, mCherry+SUMO+Ubc9 or mCherry+SENP1. Transfected cells were identified by
mCherry fluorescence. Ih was elicited by stepping the voltage from -50mV to -120 mV in 10 mV
increments (Fig 3.5A). The data showed the treatment that produced a ~50% increase in HCN2
SUMOylation (SUMO+Ubc9, Fig 3.4B) also produced a mean 77±18.8% increase in Ih Gmax
relative to control (Fig 3.5B). Overexpression of SENP1 produced a detectable but not
significant mean 31.7±14% decrease relative to control (Fig 3.5B), which was consistent with the
finding that SENP1 did not significantly alter baseline SUMOylation of HCN2 channels. The
change in Ih Gmax was not accompanied by any change in the voltage-dependence of activation
(Fig 3.5C). Neither the mean V50, nor the mean slope of the activation curve were significantly
different between control, SUMO+Ubc9, or SENP1 treatment groups (Fig 3.5C). Similarly, the
time constant for activation was not significantly different between treatment groups (Fig 3.5A).
In sum, increased SUMOylation of GFP-HCN2 produced a corresponding increase in Ih Gmax
with no change in voltage dependence or kinetics of activation.
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3.4.5

SUMOylation Increases HCN2 Channel Surface Expression

We next tested whether or not the SUMOylation-dependent increase in Ih Gmax was
accompanied by an increase in GFP-HCN2 channel surface expression. A biotinylation assay
was used on Hek-HCN2 cells that were transiently transfected with mCherry or
mCherry+SUMO+Ubc9. After 2 days, transfected cells were incubated with biotin, which binds
to cell surface proteins. The cells were then lysed, and the biotinylated proteins were pulled out
using Neutravidin. The unbiotinylated (intracellular) and biotinylated (extracellular surface)
proteins were run on a western blot, and the blot was subsequently divided at ~50kDa. The
portion of the blot containing proteins <50 kDa was probed with an antibody against actin. The
~37kDa band corresponding to actin was only seen in the intracellular fractions, indicating there
were no intracellular proteins contaminating the extracellular surface samples (Fig 3.6A). The
section of the blot corresponding to proteins >50 kDa was dually probed with an anti-GFP
antibody and an antibody against the Na+/K+-ATPase (Fig 3.6A). The doublet was detected with
the anti-GFP antibody. The band at ~120 kDa represents the Na+/K+-ATPase. The OD of the
GFP signal (entire GFP-HCN2 doublet) was normalized by that for the Na+/K+-ATPase signal.
We observed a significant mean 70.6±18.2% increase in HCN2 surface expression in cells
transfected with SUMO+Ubc9 relative to control (Fig 3.6B). Based on these findings, we
concluded that the ~77% increase in Ih Gmax observed upon enhanced GFP-HCN2 channel
SUMOylation was due, at least in part, to a ~70% increase in the surface expression of the GFPHCN2 channel.
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3.4.6

Only One of Six Putative SUMOylation Sites is Necessary for the Increase in

GFP-HCN2 Surface Expression and Ih Gmax Elicited by Overexpression of SUMO and
Ubc9
GFP-HCN2 channels can be SUMOylated in our culture system, and increased
SUMOylation leads to an augmentation of Ih Gmax due, at least in part, to enhanced GFP-HCN2
channel surface expression. Approximately 63% of all SUMOylation occurs within a
SUMOylation consensus sequence (Hendriks, D'Souza et al. 2015), e.g. ΨKXD/E, with Ψ being
a hydrophobic residue and X being any amino acid (Rodriguez, Dargemont et al. 2001, Sampson,
Wang et al. 2001, Flotho and Melchior 2013). We next investigated if HCN channels possessed
SUMOylation consensus sequences. SUMOplot freeware (www.abgent.com/sumoplot) was used
to identify potential HCN SUMOylation sites for all mouse HCN channel isoforms and for the
spiny lobster HCN channel. The amino acid sequences for all five channels were aligned,
SUMOylation consensus sequences were highlighted for all isoforms and the probability of
SUMOylation, as calculated by SUMOplot, was indicated (Fig 3.7). There were 6 putative
HCN2 SUMOylation sites with probabilities ranging from 32% to 93%. One site was
extracellular (K210) and was not considered further. Two of the five intracellular HCN2
consensus sequences (K464 and K484) were observed in all mammalian HCN channel isoforms
and in the lobster HCN channel. The other three consensus sequences were isoform/species
specific. The consensus sequence containing K669 was exclusive to mouse HCN1 and HCN2
channels. The consensus sequence that included K534 was found only in mouse HCN2 and
lobster HCN channels. The consensus sequence containing K75 was unique to the mouse HCN2
channel. Additional putative SUMOylation sites not observed in mouse HCN2 channels existed
in other mouse and lobster HCN channel isoforms.
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We next investigated if HCN2 consensus sequences were substrates for SUMOylation in
our culture system. Because K534 and K669 showed a greater than 90% probability of
SUMOylation (Fig 3.7), we chose to examine these first. These two sites were mutated
individually and together by changing the positively charged K residue to a positively charged
arginine (R), which should prevent SUMO conjugation without disrupting charge interactions
(Feliciangeli, Bendahhou et al. 2007). Three Hek cell lines stably expressing the mutated
channels were generated: Hek-HCN2 K534R+K669R, Hek-HCN2 K534R, and Hek-HCN2
K669R. Each stable mutant cell line was transiently transfected with mCherry or
mCherry+SUMO+Ubc9. After ~48hr the fraction of SUMOylated GFP-HCN2 channels was
measured as previously described for Fig 3.4. Based on our semi-quantitative measures, the
mutations did not appear to alter baseline HCN2-GFP SUMOylation in the mCherry treatment
group (mean±SEM; wild-type = 0.31±0.025, K534R+K669R = 0.41±0.04, K534R = 0.31±0.02
and K669R = 0.37±0.015; One-way ANOVA F(3,19) = 2.644, p = 0.0788). On the other hand,
the mutations did disrupt the increase in HCN2-GFP SUMOylation normally elicited by
SUMO+Ubc9 overexpression (Fig 3.8). Increased SUMOylation was no longer observed in the
Hek-HCN2 K534R+K669R cell line (Fig 3.8A) or the Hek-HCN2 K669R cell line (Fig 3.8C);
however, the Hek-HCN2 K534R cell line still displayed increased SUMOylation upon
SUMO+Ubc9 overexpression (Fig 3.8B). In sum, the data suggest that overexpression of
SUMO+Ubc9 increases SUMOylation at K669; furthermore, because SUMOylation is still
observed when this site is mutated, at least one additional site on the GFP-HCN2 channel must
be SUMOylated.
We next examined Ih Gmax in the mutant cell lines. Consistent with the previous finding,
we observed that mutating K669 but not K534 prevented the increase in Ih Gmax upon
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SUMO+Ubc9 overexpression. Ih Gmax was not significantly different between the SUMO+Ubc9
vs. control treatment groups in Hek-HCN2 K534R+K669R (Fig 3.9A) or Hek-HCN2 K669R cell
lines (Fig 3.9C). However, in Hek-HCN2 K534R cells, a 58.2±16.1% increase in Ih Gmax was still
observed in the SUMO+Ubc9 treatment group relative to control (Fig 3.9B). Together these data
suggest that SUMOylation of K669 is responsible for the increase in I h Gmax observed upon
overexpression of SUMO+Ubc9.
Lastly, we tested if mutating K669 prevented the increase in GFP-HCN2 surface
expression normally elicited by overexpression of SUMO and Ubc9. Hek-HCN2 K669R cells
were transiently transfected with mCherry or mCherry+SUMO+Ubc9 and the biotinylation assay
was performed as described for Fig 3.6. The data indicated then when K669 was mutated,
overexpression of SUMO and Ubc9 could no longer elicit an increase in GFP-HCN2 surface
expression (Fig 3.10). In sum, the K669R mutation blocked the increase in SUMOylation, Ih
Gmax and surface expression normally elicited by overexpression of SUMO+Ubc9. This suggests
that enhanced SUMOylation at K669 augments GFP-HCN2 surface expression which in turn
amplifies Ih Gmax.
3.5

Discussion
Ion channels are emerging as targets of SUMOylation. The extent to which different

classes of ion channels are SUMOylated and the function and regulation of ion channel
SUMOylation are only beginning to be investigated. Here we report, for the first time, that HCN
channels are SUMOylated in vivo and in a heterologous expression system. IP experiments with
mouse forebrain membrane preparations followed by western blotting showed that mouse HCN2
channels were post-translationally modified by SUMO1, as well as SUMO2 and/or SUMO3 in
vivo. HCN2 channels were also SUMOylated under baseline conditions in a Hek cell line stably
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expressing a GFP-HCN2 construct, and transient transfection with SUMO and the SUMOconjugating enzyme, Ubc9, increased GFP-HCN2 channel SUMOylation above baseline. This,
in turn, augmented GFP-HCN2 channel surface expression and produced a corresponding
increase in Ih Gmax without altering the voltage dependence or kinetics of activation. Using sitedirected mutagenesis of HCN2 and Hek cell lines stably expressing mutant GFP-HCN2
channels, we showed that SUMOylation at amino acid K669 was increased upon overexpression
of SUMO+Ubc9, and this alone was responsible for enhanced GFP-HCN2 channel surface
expression and augmentation of Ih Gmax. However, the K669R mutation, which prevented
SUMOylation at this site, did not alter baseline SUMOylation of HCN2 channels, suggesting an
additional site(s) on the GFP-HCN2 channel may be SUMOylated under baseline conditions.
3.5.1

Ion Channels are SUMOylated In vivo

The effect of SUMO modification on ion channels has become an area of increasing
interest. Previous studies have identified additional ion channel targets of SUMOylation, and the
effect of SUMOylation on these channels is quite diverse. For example, SUMO modification of
Kv2.1 inhibits the current by speeding time-dependent inactivation and slowing recovery from
inactivation in pancreatic cells (Dai, Kolic et al. 2009). However, SUMOylation of the same
channel in hippocampal neurons results in a depolarized shift in the voltage dependence of
activation, making the neurons more excitable (Plant, Dowdell et al. 2011). Studies looking at
SUMOylation of the Kv1.5 channel found that it produced a shift in the voltage dependence of
inactivation (Benson, Li et al. 2007). A recent study showed that in SENP2 null mice
hyperSUMOylation of Kv7 channels diminished the M-current and resulted in neuronal
hyperexcitability, leading to seizures and sudden death (Qi, Wang et al. 2014). In addition to
altering the biophysical properties of ion channels, SUMOylation can alter their surface
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expression. For example, kainite receptor SUMOylation leads to internalization of the receptor,
and this effect can be enhanced by agonist binding and PKC phosphorylation (Martin,
Nishimune et al. 2007, Konopacki, Jaafari et al. 2011, Chamberlain, Gonzalez-Gonzalez et al.
2012). Here we have shown that HCN2 channel SUMOylation at K669 increases surface
expression and Ih Gmax. It is important to note that the change in surface expression may not be
the sole explanation for the change in Ih Gmax; though it was not examined here, changes in
biophysical properties, such as an increase in the open probability (Po) of the channel, could also
contribute to the observed increase in Ih Gmax. In addition, silent channels in the membrane could
be activated by enhancing protein-protein interactions.
3.5.2

HCN channels contain multiple SUMOylation Consensus Sequences

The conjugating enzyme, Ubc9, adds SUMO to target proteins. In some cases, Ubc9 is
directed to a SUMOylation site by an external factor, such as a SIM domain or an E3 ligase. In
these instances, SUMOylation does not necessarily occur at a known consensus sequence (Flotho
and Melchior 2013). In other cases, Ubc9 itself recognizes a consensus sequence and adds
SUMO to the K in the consensus sequence. One study indicates that SUMOylation at known
consensus sequences accounts for ~63% of all SUMOylation, although this may vary with the
condition, e.g. normal growth conditions vs. heatshock (Hendriks, D'Souza et al. 2015). There
are five predicted intracellular SUMOylation consensus sequences in HCN2 (Fig 3.7). Using
Hek cell lines stably expressing wild type and mutant GFP-HCN2 channels, we clearly
demonstrated that overexpression of SUMO and Ubc9 increased SUMOylation at only one of the
five sites, K669. However, when K669 was mutated, GFP-HCN2 channel SUMOylation was still
observed, suggesting additional sites were SUMOylated under baseline conditions. Since
additional consensus sequences exist on both the GFP tag and the HCN2 channel, either or both
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could contribute to the observed baseline SUMOylation. It is not clear why SUMOylation did
not increase at these site(s) upon overexpression of SUMO and Ubc9. They may be maximally
SUMOylated and/or additional proteins or regulatory mechanisms may be necessary for
SUMOylation to occur. Alternatively, baseline SUMOylation may not occur at consensus
sequences, in which case increasing SUMO and Ubc9 should have no effect.
The five putative HCN2 consensus sequences ranged from being unique to HCN2 channels
to being conserved across all mouse HCN and lobster channel isoforms. The consensus sequence
that is known to be SUMOylated and which contains K669 is present exclusively in mouse
HCN1 and HCN2 channels. Our data indicated that SUMOylation at K669 was not necessary to
produce a functional current: Ih was not observed in whole cell patch clamp recording from
parental Hek cells, but it was recorded in Hek cells stably expressing GFP-HCN2 channels with
a K669R mutation that prevented SUMOylation at this site. Although K669 SUMOylation was
not necessary, increased SUMOylation at K669 augmented GFP-HCN2 channel surface
expression and Ih Gmax. These data suggest that SUMOylation at K669 may alter the rates of
channel trafficking to and/or from the plasma membrane and/or alter channel retention in the
plasma membrane. The surface expression of HCN1 channels can be rapidly adjusted in response
to changes in activity, including seizures (Shah, Anderson et al. 2004, Noam, Zha et al. 2010,
Jung, Warner et al. 2011). Activity can also regulate the SUMOylation of target proteins and the
expression and localization of SUMO and the SUMOylation machinery in neurons (Jaafari,
Konopacki et al. 2013, Loriol, Khayachi et al. 2013, Sun, Lu et al. 2014). Thus, it is possible that
changes in activity might alter HCN channel surface expression by altering SUMOylation at this
conserved site.
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The putative HCN2 channel SUMOylation sites at K464 and K484 were observed in all
mouse HCN channel isoforms and even in the lobster HCN channel (Fig 3.7), suggesting that
they may play important functional roles. Both K464 and K484 are in the C-linker that connects
the CNBD to the transmembrane region. The C-linker is necessary for channel trafficking and
cAMP gating (Ulens and Siegelbaum 2003, Zagotta, Olivier et al. 2003, Zhou, Olivier et al.
2004). The C-linker contains seven α-helices, A-F (Zagotta, Olivier et al. 2003); K464 lies
between α-helices A and B while K484 lies between α-helices B and C. Since SUMOylation is
thought to occur only in regions lacking secondary structure, it is noteworthy that both putative
SUMOylation sites lie just outside of the α-helices. The A and B α-helices in one subunit are
thought to interact with the C and D α-helices in a neighboring subunit (Zagotta, Olivier et al.
2003). We have not yet tested whether these two SUMOylation sites are involved in channel
folding, assembly and/or trafficking, but it may be that SUMOylation plays a fundamental role in
these processes for all HCN channels.
The K534 SUMOylation consensus site lies within the CNBD, which is also necessary
for trafficking and cAMP gating (Akhavan, Atanasiu et al. 2005). According to a previous
crystallography study of the solubilized C-terminus (Zagotta, Olivier et al. 2003), this site lies
within α-helix A of the CNBD. The K534R mutation did not appear to alter baseline
SUMOylation in our studies, nor did it prevent the increase in HCN2 SUMOylation observed
upon overexpression of SUMO+Ubc9. Together these data suggest that K534 may not be
SUMOylated in the mature channel. However, this site was assigned a high score by SUMOplot,
and it is conserved across species, which often suggests functionality. Since SUMOylation is a
dynamic and highly regulated process (Watts 2013), it may be that this site is transiently
SUMOylated in response to a specific signal not mimicked in our experiments.
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3.5.3

Potential SUMO-dependent HCN2 Channel Interactions

SUMOylation can produce several distinct physiological consequences, but its primary
function is to facilitate protein-protein interactions through the binding of a SUMO posttranslational modification on the target protein to a SUMO interaction motif (SIM) on the
interacting partner protein (Hickey, Wilson et al. 2012). Other interaction motifs also exist
(Flotho and Melchior 2013). We have demonstrated that HCN2 channel SUMOylation can
regulate surface expression, and that (putative) HCN2 SUMOylation sites are located in domains
that are important for channel trafficking and surface expression (Proenza, Tran et al. 2002, Tran,
Proenza et al. 2002, Akhavan, Atanasiu et al. 2005, Nazzari, Angoli et al. 2008). Thus, while
SIM containing interaction partners for HCN2 channels have not yet been identified, it seems
likely that they may include trafficking and scaffold proteins. HCN2 synthesis and assembly
begin in the ER where heavily glycosylated subunits associate through N- and C-terminal
domains (Proenza, Tran et al. 2002, Tran, Proenza et al. 2002). Channels transit from the ER,
through the Golgi and to the plasma membrane via their interactions with a host of proteins that
mediate vesicular trafficking. Plasma membrane HCN2 channels can be recycled. Recycled
HCN channels are stored in the endosome recycling compartments below the plasma membrane
until a signal, such as Phospholipase D activation, triggers insertion back into the plasma
membrane (Hardel, Harmel et al. 2008). SUMOylation could be involved at any of these
trafficking stages. Scaffold and trafficking proteins are known to interact with three distinct
domains in the C-terminus of the HCN2 channel: the C-linker, the CNBD, and the ~230 amino
acids distal to the CNBD (Kimura, Kitano et al. 2004, Santoro, Wainger et al. 2004, Lewis,
Schwartz et al. 2009, Han, Noam et al. 2011). S-SCAM, mint, and talamin are scaffold and
trafficking proteins that form an assemblage with HCN2 channels through unknown interactions

49

involving the distal ~230 amino acids. SUMOylation site K669 is located in this distal fragment,
suggesting that SUMOylation at this site may enhance surface expression by promoting these
assemblages (Han, Noam et al. 2011). SUMOylation in the C-linker and/or the distal fragment
could also potentially promote or prevent the binding of trafficking/scaffolding proteins like
TRIP8b (Santoro, Wainger et al. 2004, Lewis, Schwartz et al. 2009, Han, Noam et al. 2011) and
S-SCAM (Kimura, Kitano et al. 2004) to the CNBD.
3.5.4

HCN Channel SUMOylation and Neurological Disorders

Multiple neurological disease states may be linked to aberrant SUMOylation. Normally
SUMOylation of α-synuclein promotes a functional, soluble conformation of the protein, but
deSUMOylation leads to α-synuclein aggregation and cytotoxicity, which are hallmarks of
Parkinson’s Disease (Eckermann 2013). Also, the parkin gene is frequently mutated in autosomal
recessive Parkinson’s patients (Guerra de Souza, Prediger et al. 2016). Parkin is a ubiquitin
ligase that mediates the degradation of misfolded mitochondrial proteins. SUMOylation
regulates parkin shuttling from the cytosol to the nucleus, thereby controlling its availability at
the mitochondria (Um and Chung 2006). Alzheimer’s disease is characterized by the formation
of neurofibrillary tangles and amyloid-beta (Aβ)-containing plaques. Two proteins closely
associated with these features, amyloid precursor protein (APP) and tau, have recently been
identified as targets of SUMOylation (Hoppe, Salbego et al. 2015). Their improper
SUMOylation could contribute to misfolding and aggregation (Flotho and Melchior 2013).
Altering the expression of enzymes in the SUMOylation pathway can lead to seizures due, at
least in part, to hyperSUMOylation of Kv7 channels (Qi, Wang et al. 2014). If SUMOylation is
globally disrupted in a given disease, then multiple targets could be affected, including HCN2
channels. Indeed, HCN2 channel activity is progressively reduced in a mouse model of
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Parkinson’s disease leading to altered pacemaking in globus pallidus neurons (Chan, Glajch et al.
2011), and altered HCN2 channel expression has been associated with seizures in a variety of
instances (Ludwig, Budde et al. 2003, DiFrancesco, Barbuti et al. 2011, Nakamura, Shi et al.
2013, DiFrancesco and DiFrancesco 2015). Future studies on the function and regulation of
HCN channel SUMOylation could provide important insights into HCN2 channel dysfunction in
these disease states.
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Figure 3.1 Mouse HCN2 is SUMOylated in vivo
Mouse forebrain non-denatured (A) and denatured (B) membrane fractions were used in
immunoprecipitation experiments (IP) with an antibody against HCN2 or IgG (negative control).
Western blots containing the IP products were probed for HCN2, SUMO1, and SUMO2/3. The
experiment was repeated three times using the brains from three different mice. Representative
western blots are shown from a single experiment. The red dots indicate non-specific products
pulled down in the IP. The single band at ~120kDa represents HCN2 channels. The asterisk
indicates a non-covalently bound, SUMOylated protein
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Figure 3.2 Establishing a culture system to investigate HCN2 channel SUMOylation
Cell lysates from a Hek cell line stably expressing GFP-HCN2 channels (A) and the parental
Hek cell line (B) were used in IP experiments with an antibody against GFP. Western blots (WB)
containing the lysate (L) and IP products (IP) were then probed with anti-HCN2 and anti-GFP
antibodies. A doublet was recognized by both antibodies in the stably transfected but not parental
Hek cell line, suggesting that the doublet represents GFP-HCN2 channels. The band present at
50kDa in the IP lanes corresponds to the heavy chain of the anti-rabbit antibody used in the IP
experiment. The anti-rabbit secondary antibody used in the GFP western blot produced a strong
signal. The anti-mouse secondary antibody used in the HCN2 western blot produced a much
weaker signal
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Figure 3.3 GFP-HCN2 channels are SUMOylated in Hek-HCN2 cells
Cell lysates from the Hek-HCN2 cell line were used in IP experiments with an antibody against
GFP. Western blots containing the IP products were then probed with an anti-GFP antibody or an
anti-SUMO2/3 antibody. Parental Hek cell lysates were also probed with the anti-SUMO2/3
antibody. The anti-SUMO2/3 antibody recognized the GFP-HCN2 doublet in the Hek-HCN2 cell
line, but not in the parental cell line, suggesting that GFP-HCN2 channels are SUMOylated

54

55

Figure 3.4 Transient transfection with SUMO and Ubc9 leads to an increase in GFPHCN2 channel SUMOylation
The stable Hek-HCN2 cell line was transiently transfected with mCherry (control), or
mCherry+SUMO+Ubc9, or mCherry+SENP1. Two days after transfection, cell lysates were
used in IP experiments with an anti-GFP antibody. IP products were resolved with SDS-PAGE
and transferred to western blots (WB). Blots were probed with an anti-SUMO2/3 antibody. After
recording the result, blots were stripped and reprobed with an anti-GFP antibody. (A)
Representative blots showing typical chemiluminescent signals for the GFP-HCN2 channel
doublet after probing with the anti-SUMO2/3 antibody (upper panel) followed by stripping and
re-probing with the anti-GFP antibody (bottom panel). Note that the amount of IP product varied
between experiments but not across treatment groups as determined by measures of the GFP
OD’s (One-way ANOVA, F(2,16)= 0.1285; p=0.8804). (B) The fraction of SUMOylated HCN2
channels in each treatment group (SUMO doublet OD÷GFP doublet OD, see text) is plotted as
the mean+SEM. The treatment and the n are shown below each plot. Each n represents a single
plate that was transfected and carried through the experiment to produce a single lane on a
western blot. Asterisk represents a statistically significant difference from control (One-way
ANOVA with a Dunnett’s post-hoc, F(2,16)= 4.121; p=0.0360)
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Figure 3.5 Increased HCN2 channel SUMOylation augments Ih Gmax
Ih was measured in Hek-HCN2 cells transiently transfected with either mCherry (control),
mCherry+SUMO+Ubc9, or mCherry+SENP1. For each treatment group, data were pooled from
≥ 3 transfections. (A) Representative traces for each treatment group, elicited by stepping the
voltage from -50mV to -120mV in 10mV increments. Scale bars, 500ms and 200pA. The
kinetics of activation at -120mV were not altered across treatment groups. Mean activation time
constants: control, 400.9 ± 23.01; SUMO+Ubc9, 407.3 ± 33.67; SENP1, 497.4 ± 50.79; Oneway ANOVA, F(2,32)= 2.224; p=0.1246. (B) Plots of Ih Gmax for each treatment group. Each
data point represents a single cell. Bar represents the mean. Transfection with SUMO+Ubc9
significantly increased Ih Gmax relative to SENP1 and control treatment groups (asterisks, p<0.05;
One-way ANOVA with Tukey’s post-hoc, F(2,28)= 13.23; p< 0.0001). (C) Plots of voltage
dependence of activation. Each data point represents the mean ± SEM. There were no significant
differences between treatment groups for mean V 50 (control, -93.88 ± 1.12; SUMO+Ubc9, -91.6
± 1.29; SENP1, -87.8 ± 3.03; One-way ANOVA, F(2,32)= 3.006; p=0.0636) or mean slope
(control, -6.61 ± 0.29; SUMO+Ubc9, -7.42 ± 0.41; SENP1, -6.84 ± 0.4; One-way ANOVA,
F(2,32)= 1.439; p= 0.252)
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Figure 3.6 Increased SUMOylation augments HCN2 channel surface expression
GFP-HCN2 channel cell surface expression was monitored using a biotinylation assay.
Hek-HCN2 cells were transiently transfected with mCherry alone or mCherry+SUMO+Ubc9.
Two days after transfection cultures were biotinylated and cell surface proteins were isolated
from cell lysates using Neutravidin. Both the intracellular and cell surface fractions were run on
a western blot and probed with antibodies recognizing GFP, Na+/K+-ATPase, and Actin. (A)
Representative western blots. (B) Plots depicting average normalized GFP-HCN2 channel
surface expression (GFP doublet OD÷Na+/K+-ATPase OD). The treatment and the n are shown
below the graph. Each n represents a single plate that was transfected, biotinylated and carried
through the experiment to produce a single lane on a western blot. Asterisk indicates significant
difference between treatment groups (Student’s t-test, p<0.05)
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Figure 3.7 Identification of HCN2 channel SUMOylation sites
Amino acid sequences for the vertebrate and invertebrate HCN channel were aligned: mouse
HCN1 (NP_034538), mouse HCN2 (NP_032252), mouse HCN3 (NP_032253), mouse HCN4
(NP_001074661), spiny lobster HCN (ABI94038). Putative SUMOylation sites predicted by
SUMOplot freeware are indicated in blue (not mutated this study) or red (mutated in this study).
The six transmembrane domains (yellow) and CNBD (blue) have been highlighted
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Figure 3.8 Overexpression of SUMO and Ubc9 enhances SUMOylation at K669
The three mutant cell lines (A-C) were transiently transfected with mCherry or
mCherry+SUMO+Ubc9. Cell lysates were used in IP experiments with anti-GFP antibodies.
Western blots containing IP products were probed with the anti-SUMO2/3 antibody, stripped and
reprobed with the anti-GFP antibody. Top Panel: Representative blots showing the GFP-HCN2
doublet that was measured. Bottom Panel: Plots of the fraction of SUMOylated GFP-HCN2
channels in each mutant cell line, mean+SEM. The treatment and the n are shown below the
graph. Each n represents one plate that was transfected and carried through the experiment to
produce a single lane on a western blot. Asterisk, significantly different (Student’s t-test, p<0.05)
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Figure 3.9 Enhanced SUMOylation at K669 augments Ih Gmax
Ih Gmax was measured following transient transfection with mCherry or mCherry+SUMO+Ubc9
in the three mutant cell lines (A-C). Top panel: Representative traces for each treatment group
for each mutant cell line. Scale bars, 500 ms, and 500 pA, Bottom Panel: Plots of normalized Ih
Gmax (Gmax ÷ mean mCherry G max) for each mutant cell line. Ih Gmax was normalized to account
for differences in overall expression of the HCN2 channels between the different mutant cell
lines, most likely due to difference in the copy number of the plasmid integrated into the
genome. Each data point represents a single cell. Asterisk, significantly different (Student’s t-test
p<0.05, recordings were pooled from ≥ 3 separate transfections)

62

63

Figure 3.10 Enhanced SUMOylation at K669 increases GFP-HCN2 channel surface
expression
The K669R mutant cell line was transiently transfected with mCherry or
mCherry+SUMO+Ubc9, followed by the biotinylation assay to measure GFP-HCN2 surface
expression. (A) Representative blots probed with anti-GFP and anti-Na/K ATPase antibodies (B)
Plots of normalized GFP-HCN2 channels in each treatment group. The treatment and the n are
shown below the graph. Each n represents a single plate that was transfected, biotinylated and
carried through the experiment to produce a single lane on a western blot. There was no
significant difference between treatment groups (Student’s t-test, p=0.5606)
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Table 3.1 Primary Antibodies
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Table 3.2 Site directed mutagenesis primers
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4.1

Abstract
Homeostatic mechanisms can co-regulate ionic conductances to stabilize neuronal

activity features. In the Lateral Pyloric neuron (LP) of the crustacean stomatogastric ganglion, a
positive correlation between the transient potassium current (IA) and the hyperpolarizationactivated current (Ih) stabilizes activity phase. Previous studies indicated a slow mechanism
produced a positive correlation between the transcripts encoding the channels mediating LP IA
and Ih. Here we show a second mechanism exists whereby activity can rapidly co-regulate the
currents by controlling the level of post-translational modification by Small Ubiquitin-like
Modifier (SUMO). Changes in activity produced opposing changes in the SUMOylation
associated with LP IA and Ih. SUMOylation had opposing effects on LP IA and Ih amplitudes.
Thus activity-dependent SUMOylation specified a positive correlation between LP I A and Ih.
Tonic nM DA reconfigured the targets of the SUMOylation machinery, suggesting that the
composition of modulatory tone will permit or prevent the correlations specified by activitydependent SUMOylation.
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4.2

Introduction
Homeostatic processes stabilize neuronal output by producing compensatory changes in

synaptic strengths and ionic current densities in response to altered activity (O'Leary and Wyllie
2011, Davis 2013). One of the earliest demonstrations that neuronal output could be stabilized by
adjusting ionic current densities in an activity-dependent manner was a computational model
based on the lateral pyloric neuron (LP) that produces rhythmic bursts of action potentials (Fig
4.1A). The computational neuron attained a robust output by modulating the maximal
conductances (G max) of its seven ionic currents in response to activity perturbations that altered
Ca2+ concentration (LeMasson, Marder et al. 1993). Subsequent experimentation demonstrated
that compensatory changes in current densities may be evoked by a variety of activity
perturbations produced by physically isolating network neurons (Turrigiano, Abbott et al. 1994),
chronic pharmacological applications (Desai, Rutherford et al. 1999, Ishikawa, Mu et al. 2009,
O'Leary, van Rossum et al. 2010, Driscoll, Muraro et al. 2013) and genetic knock-out/overexpression of a specific conductance(s) (Linsdell and Moody 1994, Swensen and Bean 2005,
Peng and Wu 2007). These experimental approaches inevitably highlighted slow mechanisms
that operated at the level of transcription and/or translation (Driscoll, Muraro et al. 2013,
Kirchheim, Tinnes et al. 2013, Pozzi, Lignani et al. 2013), which led to computational models of
activity homeostasis that used slow feedback control mechanisms to regulate ionic current
densities (Golowasch, Casey et al. 1999, Olypher and Prinz 2010, O'Leary, Williams et al. 2014).
The term Homeostatic Intrinsic Plasticity (HIP) is used to describe slow, activity-dependent,
compensatory adjustments in ionic current densities that persist beyond the initiating stimuli
(Mitchell and Johnson 2003). While HIP appears to stabilize neuronal output over the long-term,
it cannot offset the fast positive feedback associated with Hebbian learning (Zenke, Gerstner et
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al. 2017). There are examples of rapid compensatory changes in ionic current densities that
stabilize neuronal activity over shorter timescales (van Welie, van Hooft et al. 2004, Fan, Fricker
et al. 2005, Steinert, Robinson et al. 2011). These mechanisms are thought to act posttranslationally and produce transitory alterations in current densities, as such, they do not fall
under the heading of plasticity. Transient changes that do not significantly outlast their stimuli
are classified as modulation (Mitchell and Johnson 2003), and here we use the term Homeostatic
Intrinsic Modulation (HIM) to mean rapid and transitory, activity-dependent modifications in
ionic current densities that compensate for changes in activity.
We have been studying HIM in LP, a component of the pyloric pattern generating circuit
which produces a constant rhythmic output (Marder and Bucher 2007). Although the frequency
of the cyclic pyloric output can vary, the phase relationships of the neurons within each rhythmic
cycle are invariant (Bucher, Prinz et al. 2005, Goaillard, Taylor et al. 2009), suggesting that a
homeostatic mechanism(s) maintains LP activity phase. Covariation of ionic conductances can
maintain specific neuronal activity features (Hudson and Prinz 2010, Soofi, Archila et al. 2012,
Zhao and Golowasch 2012). LP phase depends, in part, on the balance between the transient
potassium (IA) and hyperpolarization activate (Ih) currents (Harris-Warrick, Coniglio et al. 1995,
Zhao and Golowasch 2012). These two conductances are positively correlated in LP neurons
(Temporal, Desai et al. 2012). We previously demonstrated that reducing LP IA with bathapplied 5µM DA (Rodgers, Fu et al. 2011, Krenz, Hooper et al. 2013) or 4mM 4-AP (Krenz,
Rodgers et al. 2015) altered LP phasing, but then, phase recovered over minutes. Further
investigation showed that when the preparation was superfused with 5nM DA, incremental bidirectional changes in activity produced corresponding changes in LP I h with a time constant of
~10min (Krenz, Rodgers et al. 2015). The phase recovery observed in our experiments could be
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explained as follows: the reduction in IA produced an incremental change in activity, which in
turn led to a similar reduction in Ih through a DA-enabled, Ca2+-dependent mechanism, and this
restored the correlation. These findings are somewhat perplexing. Presumably, manipulation of
non-IA currents could produce a comparable change in activity, leading to an incremental
reduction in LP Ih that would then disrupt the correlation between IA and Ih. One possibility is
that IA and Ih are similarly regulated by activity. But if this were true, then a given change in
either of the two conductances must alter activity in the same manner to maintain the correlation.
This seems unlikely given that IA and Ih are opposing conductances. It is reasonable to think that
HIP and HIM are guided by similar principles. Studies on HIP show that multiple currents are
simultaneously correlated (Zhao and Golowasch 2012) and that current compensation is nonreciprocal (Kim, Vienne et al. 2017). A recent computational model of HIP that required a
neuron to preserve a set Ca2+ concentration was able to successfully maintain conductance
correlations and activity features by regulating ion channel transcription in an activity-dependent
fashion (O'Leary, Williams et al. 2014). A major limitation of this model was that it assumed
functional protein levels were determined solely by mRNA abundance. This model could be
improved by incorporating compensatory, activity-dependent post-translational mechanisms, but
the molecular pathways involved in HIM are currently unknown.
In this study, we delve into the molecular mechanism responsible for the correlation
between LP IA and Ih and how it is regulated by modulatory tone. We reasoned that the Small
Ubiquitin-like Modifier (SUMO) could be involved in HIM because it has been shown to
regulate the surface expression of the Hyperpolarization-activated, Cyclic Nucleotide-gated
(HCN) channels that mediate Ih (Parker, Welch et al. 2016). SUMO is a peptide that is posttranslationally conjugated to target proteins in order to alter their protein-protein interaction
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(Flotho and Melchior 2013). Target protein SUMOylation states are dynamically regulated by
the opposing actions of conjugating and deconjugating enzymes (Flotho and Melchior 2013).
The SUMO system is thought to coordinately regulate groups of proteins that are functionally
related (Hay 2005, Jentsch and Psakhye 2013, Seifert, Schofield et al. 2015), and it has the
potential to coordinate fast and slow negative feedback loops by simultaneously decorating
proteins mediating HIM, e.g., ion channels, and HIP, e.g., transcription factors. Neuronal activity
and activation of G-protein coupled receptors can alter the location and activity of the
SUMOylation machinery (Jaafari, Konopacki et al. 2013, Loriol, Khayachi et al. 2013, Loriol,
Casse et al. 2014), and target proteins can be SUMOylated in an activity-dependent manner
(Chamberlain, Gonzalez-Gonzalez et al. 2012, Sun, Lu et al. 2014). SUMO is emerging as an
important regulator of synaptic plasticity and in some cases, it is necessary for long-term
potentiation (LTP) (Jaafari, Konopacki et al. 2013), long-term depression (LTD) (Chamberlain,
Gonzalez-Gonzalez et al. 2012), and synaptic scaling (Craig, Jaafari et al. 2012); thus, the
SUMO system also has the potential to coordinate positive and negative feedback loops. Here we
explore the function of SUMOylation in specifying the correlation between LP I A and Ih, and the
permissive role of tonic 5nM DA in this process.
4.3

Methods
4.3.1

Animals

California spiny lobsters, Panulirus interruptus, were purchased from Marinus Scientific
(Long Beach, CA) and Catalina Offshore Products (San Diego, CA). Lobsters were maintained
at 16◦C in aerated and filtered seawater. Animals were anesthetized on ice before dissection.
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4.3.2

Chemicals

Tetrodotoxin (TTX) was purchased from Tocris Bioscience (Bristol, UK), Tween20 was
purchased from Fisher Scientific and all other chemicals were purchased from Sigma-Aldrich
(St. Louis, MI, USA). DA was made fresh every 30min to minimize oxidation.
4.3.3

Antibodies

An antibody against the lobster HCN channel (anti-HCN) was synthesized. DNA
corresponding to amino acids 362-390 (Genbank Accession# DQ865250) was cloned into a
PGex vector (Amersham) and the peptide was isolated according to the manufacturer’s
instructions. The peptide served as an immunogen and was injected into a rabbit. Serum obtained
from an immunized rabbit was affinity purified on a column containing the antigenic peptide.
Antibody specificity was demonstrated in IP and western blot experiments using Hek cells that
stably overexpressed the lobster HCN channel (Supp Fig 4.2).
Bethyl Laboratories (Montgomery, TX) was contracted to produce a custom affinity
purified goat polyclonal antibody against a peptide corresponding to ORF-J (5’CVGGPPLHPSAITTTNTNTAT-3’) of the shal (Kv4) protein (Baro, Quinones et al. 2001).
Anti-ORF-J and a previously validated antibody against a different region of the lobster Kv4
protein (Baro, Ayali et al. 2000) recognized the same ~75kD band on western blots containing
lobster nervous system protein lysates (Supp Fig 4.2).
All other antibodies were commercially obtained as indicated in the text and validated as
indicated in Supp Fig 4.1 and Supp Fig 4.2. All secondary antibodies were obtained from
Jackson ImmunoResearch Laboratories (West Grove, PA).
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4.3.4

STNS Dissection and LP Identification

The stomatogastric nervous system (STNS) was dissected and pinned into a Sylgard dish.
The stomatogastric ganglion (STG) was desheathed and isolated with a Vasoline well. The STG
was constantly superfused with aerated Panulirus saline (479mM NaCl, 12.8mM KCl, 13.7mM
CaCl2, 39mM Na2SO4, 10mM MgSO4, 2mM glucose, 4.99mM HEPES, 5mM TES at pH 7.4).
Extracellular recordings were obtained by placing stainless-steel pin electrodes, connected to a
differential AC amplifier (A-M Systems, Everett, WA, USA), directly against the pyloric dilator
nerve (pdn) and lateral ventricular nerve (lvn) and insulating them with Vasoline. Intracellular
somatic recordings were obtained using a high resistance electrode filled with 3M KCl (20–30
MΩ) and an Axoclamp 900A amplifier (Axon Instruments, Foster City, CA, USA). Neurons
were identified by correlating action potentials from somatic intracellular recordings with
extracellularly recorded action potentials on identified motor nerves, and by their characteristic
shape and timing of oscillations. The process of dissection and cell identification took ∼2–4h.
4.3.5

Somatic Two-Electrode Voltage Clamp (TEVC)

All experiments were performed at 19–22◦C as measured with a temperature probe in the
bath. Temperature changed by less than 1◦C during an experiment. For TEVC experiments LP
was impaled with two low resistance glass microelectrodes filled with 3M KCl (7-10MΩ)
connected to an Axoclamp 900A amplifier. The STG was superfused with Panulirus saline
containing TTX (100nM) to block voltage-dependent Na+ channels. No other ion channel
blockers were included.
LP Ih was elicited from a holding potential of -50mV using a series of 4sec voltage steps
from the holding potential of -50mV to -120mV in 10 mV increments with 6sec between each
step. LP Ih steady state peak current was measured by subtracting the initial fast leak current
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from the slowly developing Ih at the end of each voltage step. Current was converted to
conductance using Erev=-35mV (Kiehn and Harris-Warrick 1992) and fitted to a first order
Boltzmann equation.
LP IA was measured as the peak difference current between a 50ms depolarizing step to
+40mV that was preceded by a 200msec prepulse to -90mV vs. -40mV (Baro, Levini et al.
1997). IA is largely blocked by 4mM 4-AP (Tierney and Harris-Warrick 1992). In our
experiments, 5mM 4-AP blocked approximately 85-90% of the peak current. The current that
remained in 4-AP appeared to be a mix of inward and outward currents. An inward current
observed from ~ -10 to +20mV could be blocked by 200 M Cd2+ and was most likely the
previously described small (~6nA), transient P/Q type calcium current that has a steady-state
inactivation profile highly similar to IA in crustacean motor neurons (Ransdell, Temporal et al.
2013). Ca2+ currents could not be blocked since we were studying activity-dependent changes in
IA and Ih. The outward currents observed in 4-AP were presumably residual IA, IKCa and IKD. The
small mixed current that remained in 4-AP was not obviously modulated by activity in the
presence or absence of 5nM DA (Kruskal Wallis test, no DA: p=0.9286, n=3; 5nM DA:
p=0.5107, n=3), suggesting that the activity- and DA-dependent changes we observed
represented alterations in peak IA.
4.3.6

SUMO cloning

A complete Panulirus interruptus SUMO cDNA was isolated using a combination of
degenerate PCR and RACE. Total RNA was isolated from lobster nervous system tissue with
Trizol and used as the template in a reverse transcription with Superscript according to
manufacturer’s instruction. The resulting cDNA served as a template in a degenerate PCR and
RACE reactions (Baro, Cole et al. 1994). Degenerate primers (Table 4.1) were designed based
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on an alignment of Drosophila melanogaster Smt3 (Genbank accession:NM_058063), Mus
musculus SUMO 2 (Genbank accession:NM_133354), and Mus musculus SUMO 3 (Genbank
accession:BC115488). The predicted ~180bp PCR product was gel isolated and cloned into a
pDrive vector (Qiagen) and sequenced. Lobster specific RACE primers (Table 4.1) were
designed. The 3’ end of the SUMO transcript was obtained using lobster specific forward
primers (Table 4.1; Specific For1 and For2) and a SMARTer RACE kit (Clontech), following the
manufacturer’s instructions. The 5’ end of the SUMO transcript was obtained using lobster
specific reverse primers (Table 4.1; Specific Rev1 and Rev2) and a FirstChoice RLM RACE Kit
(Ambion). All sequencing was performed by the GSU DNA core facility, and sequences were
analyzed and manipulated with the Lasergene 10 suite of DNASTAR software.
4.3.7

Tat-SUMO Peptide Synthesis

cDNA representing the activated form of lobster SUMO, i.e. ending in diglycine (Supp
Fig 4.1), was obtained in a PCR using lobster specific primers (Table 4.1; Tat-SUMO For and
Rev). Standard recombinant DNA techniques were used to clone the predicted 274bp gel isolated
PCR product into the EcoRI site of the pcDNA3 Tat HA vector (a gift from Matija Peterlin
(Cujec, Okamoto et al. 1997); Addgene plasmid #14654), thereby creating an N-terminal TatHA-His tagged SUMO construct. In order to synthesize the Tat-SUMO peptide, the plasmid was
transformed in BL21-CodonPlus (DE3)-RIPL E. coli (Agilent). A single isolated colony was
grown overnight in 200ml of broth containing ampicillin (100µg/ml) at 37◦C with agitation. The
200ml overnight culture was then added to 1L of broth containing 500µM IPTG to induce
expression of the peptide, and further incubated for 5hr. Cells were pelleted at 8,000rmp for
10min at 4◦C, and the pellet was washed with ice cold PBS (137mM NaCl, 2.7mM KCl, 10mM
Na2HPO4, 1.8mM KH2PO4, pH7.4). Pelleted cells were resuspended in 20ml of Buffer Z (8M
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Urea, 100mM NaCl, 20mM HEPES, pH8) and sonicated on ice using a 10sec “on” 30sec “off”
protocol at 15% amplitude for a total of 10min. Sonicate was cleared by centrifuging at
12,000rpm for 10mins at 4◦C. Cleared sonicate was equilibrated with 10mM imidazole and
incubated with 10ml of Ni-NTA agarose resin (Qiagen) at 4◦C for 1hr. Resin was washed with
100ml of Buffer Z equilibrated with 10mM imidazole. Peptide was eluted with incrementally
increasing concentrations of imidazole (100, 250, 500mM, and 1M; 10ml each) and the buffer
was exchanged for PBS with 10% glycerol using PD-10 desalting columns (GE Healthcare).
Peptide concentration was determined by BCA assay (Pierce).
4.3.8

Immunoprecipitation and Western Blots

Lobster nervous system lysates were prepared by homogenizing lobster nervous system
tissue in NP-40 lysis buffer (50mM Tris HCl pH7.4, 150mM NaCl, 1% NP-40, 20mM NEM,
protease inhibitor cocktail at 1:100). Homogenate was incubated at 4 ◦C with agitation and then
centrifuged at 12,000rpm for 20min to pellet cell debris. Protein concentration was determined
by BCA assay (Pierce). Immunoprecipitation (IP) was performed using Dynabeads Protein G
(Invitrogen). Briefly, 10µg of antibody was incubated with the beads in 0.1M Na acetate pH 5.3
for 1hr at room temperature with agitation. Beads were washed three times with 0.1M Na acetate
pH 5.3 plus 0.01% Tween-20, 2mg of cell lysate was added to the beads and the mixture was
incubated for 90min at room temperature with agitation. Finally, the beads were washed three
times with PBS plus 0.01% Tween-20 and eluted in 20μl of 50mM Glycine pH 2.8 by heating to
70◦C for 10min. Western blot experiments were as previously described (Parker, Welch et al.
2016). Primary antibody concentrations used for western blots were as follows: anti-HCN,
1:5000, anti-ORF-J, 1:4000, anti-SUMO, 1:4000.
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4.3.9

Statistical Analysis

All data were analyzed using Prism 7 (Graphpad Software Inc.). No statistical methods
were used to compute sample size. Each data set was checked for normality and homogeneity of
variance and unless otherwise stated data were analyzed using parametric statistical tests. In all
cases, the significance threshold was set at p < 0.05. Values that were greater than two standard
deviations from the mean were considered statistical outliers and were excluded from the data
set. ANOVA’s were followed by post hoc tests as indicated. All values are presented as the
mean±SEM.
4.4

Results
4.4.1

DA reconfigures the activity-dependence of LP Ih and IA

LP phase depends, in part, upon a positive correlation between LP I A and Ih (Zhao and
Golowasch 2012). When LP phase is disrupted by reducing LP IA, phase can recover over
minutes, but only in the presence of tonic nM DA; and, tonic nM DA permits activity to regulate
LP Ih (Rodgers, Fu et al. 2011, Krenz, Hooper et al. 2013, Krenz, Rodgers et al. 2015). We
hypothesize that LP IA is regulated by activity in the presence and/or absence of DA, and that
DA allows activity-dependent co-regulation of IA and Ih to maintain LP phase. We tested this
hypothesis by examining if/how activity regulated LP IA in the presence and absence of tonic nM
DA.
LP shows spontaneous ~1Hz, ~20mV oscillations in membrane potential that traverse the
~ -60 to -40mV range. There is a plateau of variable duration at the depolarized potential (Fig
4.1A). This slow wave activity is generated in the somatodendritic compartment. Spiking activity
is generated at the spike initiation zone on the axon/primary process. Spikes do not actively
propagate into the somatodendritic compartment; rather, they passively spread and can be seen
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riding on the depolarized plateau in somatic intracellular recordings (Fig 4.1A). Duty cycle,
defined as plateau duration divided by cycle period, represents the fraction of the cycle during
which LP is maximally depolarized. We previously demonstrated that changes in duty cycle can
regulate LP Ih in the presence of tonic nM DA (Fig 4.1B). We used the same standard paradigm
to investigate whether changes in slow wave activity affected LP IA in the presence and absence
of tonic 5nM DA. LP spontaneous slow wave and spike activities were blocked with 10-7M
TTX, and TEVC was used to implement a repetitive voltage step that mimicked slow waves (Fig
4.1A).
The experiment is diagrammed in Fig 4.1A. The preparation was dissected and
continuously superfused with saline. The LP neuron was identified with electrophysiological
recordings. At t=-10min LP plateau duration, cycle period, peak and nadir voltages were
measured, and three voltage protocols were constructed for that particular neuron using
Clampex. A 0%ΔDC protocol exactly mimicked LP plateau duration, cycle period, peak and
nadir voltages. A +50%ΔDC protocol increased the duration of the depolarized step by 50% and
decreased the time between steps to maintain a constant cycle period. A -100%ΔDC protocol
abolished slow waves by holding LP at its resting potential in TTX (-59mV on average) with no
voltage step applied. TTX was applied at t=-5min, and the voltage protocols were implemented
as depicted. The percent change in the peak IA resulting from the +50%ΔDC and -100%ΔDC
relative to 0%ΔDC voltage protocols was plotted (Fig 4.1C). The results demonstrated that in the
absence of tonic 5nM DA, peak LP IA was regulated by slow wave activity in a manner very
similar to that observed for LP Ih Gmax in the presence of DA. The -100%ΔDC protocol
significantly increased the mean peak LP IA by 13 ± 2.2% while the +50%ΔDC protocol
produced a significant 14 ± 3.3% decrease in the mean peak LP IA.
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In order to test the effect of tonic 5nM DA, a separate series of experiments was
performed exactly as described except that 5nM DA was added to the superfusate immediately
after the first measure of LP IA (t=0). Previous work showed tonic 5nM DA did not obviously
alter LP IA Gmax over the short term (Zhang, Rodgers et al. 2010, Rodgers, Krenz et al. 2011,
Rodgers, Krenz et al. 2013). The addition of 5nM DA to the superfusate abolished slow wave
activity-dependent changes in LP IA (Fig 4.1C). These data disproved our hypothesis. Even
though changes in slow wave activity similarly regulated LP IA and Ih, tonic nM DA
simultaneously disabled and enabled their respective activity-dependence. Thus, the two
conductances would not be correlated in the presence of tonic nM DA alone (i.e. all modulatory
input blocked with TTX and 5nM DA added to a constant superfusate). However, we have
shown that addition of DA to an unblocked preparation (no TTX to block modulatory input)
permitted phase recovery (Rodgers, Fu et al. 2011, Krenz, Rodgers et al. 2015). This suggests
that slow wave activity may correlate LP IA and Ih under the appropriate modulatory conditions.
4.4.2

Logic supporting link between SUMOylation and activity-dependent regulation

of LP IA and Ih
We previously demonstrated that tonic 5nM DA permitted bi-directional LP Ih activitydependence by eliciting two simultaneous PKA-dependent events that could be
pharmacologically uncoupled (Krenz, Rodgers et al. 2015): event 1- a ~12% activity-independent
increase in LP Ih Gmax, and event 2- a calcineurin-mediated decrease in LP Ih Gmax. Calcineurin is
a Ca2+-calmodulin (CaM)-dependent phosphatase, and event 2 relied on Ca2+ entry through
voltage-gated Ca2+ channels and Ca2+ release from stores, suggesting a Ca2+ induced Ca2+ release
process. Bi-directional activity-dependence was achieved through the additive effects of events 1
and 2. Since event 1 was activity-independent, it was constant in all three voltage protocols
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(~12% increase in Ih Gmax). On the other hand, event 2 (Ca2+-dependent decrease in Ih Gmax) was
minimal, maximal and intermediate during the -100%ΔDC, +50%ΔDC, and 0%ΔDC protocols,
respectively. The addition of events 1 and 2 produced an increase and a decrease in LP Ih Gmax,
respectively, during the -100%ΔDC and +50%ΔDC protocols relative to the 0%ΔDC protocol
(Fig 4.1B). SUMOylation of mouse HCN channels, which mediate I h, increased their surface
expression and augmented Ih Gmax in human embryonic kidney (Hek) cells (Parker, Welch et al.
2016). We therefore surmised that events 1 and 2 could correspond to an increase and decrease
in HCN channel SUMOylation, respectively. Here we begin to test this hypothesis.
4.4.3

HCN and Kv4 channels are SUMOylated in vivo

To determine if lobster HCN and Kv4 channels, which respectively mediate I h and IA,
were SUMOylated in vivo, we performed immunoprecipitation (IP) experiments with lobster
CNS protein lysates followed by western blotting. IP experiments were carried out using custom
affinity-purified antibodies against the lobster HCN channel (anti-HCN), the lobster Kv4 channel
(anti-ORF-J) and IgG (negative control). Western blots containing the resulting IP products were
probed with a commercially available affinity-purified antibody against SUMO (anti-SUMO),
and either anti-HCN (Fig 4.2A) or anti-ORF-J (Fig 4.2B). Both HCN and Kv4 channels appeared
to be SUMOylated in vivo. The anti-HCN and anti-SUMO antibodies recognized multiple
matching bands in the anti-HCN but not the IgG IP product. The bands were in the correct size
range for post-translationally modified HCN channel alternately-spliced isoforms (Ouyang,
Goeritz et al. 2007). The anti-ORF-J and anti-SUMO antibodies recognized a single,
appropriately sized, matching band in the anti-ORF-J but not the IgG IP product. The antiSUMO antibody recognized additional bands not recognized by the channel antibodies in both
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the anti-HCN and anti-ORF-J but not the IgG IP products. These may represent SUMOylated
proteins that non-covalently interact with the channels.
4.4.4

SUMOylation is necessary for activity-dependent changes in LP Ih and IA

We next determined if Ih and IA were affected by anacardic acid, a cell permeable
SUMOylation blocker (Fukuda, Ito et al. 2009). Either Ih or IA was measured, then 100µM
anacardic acid was or was not added to the superfusate and a 1hr 0%ΔDC voltage protocol was
applied followed by TEVC to re-measure the current. No significant changes were observed in
the absence of anacardic acid (Wilcoxon test, p>0.1, n=3 each for I h and IA). In the presence of
anacardic acid, the mean LP Ih Gmax significantly decreased by 14±4.5% and the mean peak IA
significantly increased by 9.7±2.8% (Fig 4.3A). These data suggest that dynamic SUMOylation
contributes to the maintenance of LP Ih and IA. We asked if anacardic acid could also block
activity-dependence. Experiments similar to those diagrammed in Fig 4.1A were repeated except
that anacardic acid was added to the superfusate for 1hr prior to the addition of TTX. The data
indicated that blocking SUMOylation with anacardic acid abolished the DA-enabled activitydependence of LP Ih (Fig 4.3B) and the activity-dependence of LP IA in the absence of DA (Fig
4.3C). These data indicated that SUMOylation was necessary for activity-dependent changes in
LP Ih and IA.
4.4.5

Enhanced SUMO availability converts bi-directional into one-way DA-enabled

LP Ih activity-dependence
If dynamic SUMOylation regulates LP Ih Gmax, then enhancing SUMOylation should
have the opposite effect of blocking SUMOylation. Furthermore, if DA enables activitydependent SUMOylation, then enhancing SUMOylation should disrupt the permissive effect of
tonic 5nM DA. We tested these hypotheses. The enzyme Ubc9 covalently links SUMO to a
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lysine on a target protein (Desterro, Thomson et al. 1997). Ubc9 can either recognize a SUMO
consensus sequence on a target protein and conjugate SUMO to the consensus sequence, or Ubc9
can be directed to a target by an E3 ligase or a SUMO Interaction Motif (SIM), in which case
SUMOylation does not occur at a consensus sequence (Flotho and Melchior 2013).
Approximately 63% of all SUMOylation occurs at consensus sequences, though this can change
in a state-dependent manner (Hendriks and Vertegaal 2016). Simply increasing the concentration
of SUMO and/or Ubc9 can enhance SUMOylation at consensus sequences (Dai, Kolic et al.
2009). We used this method to increase mouse HCN2 channel SUMOylation at an identified
consensus sequence in a heterologous expression system, which resulted in augmentation of
channel surface expression and Ih Gmax (Parker, Welch et al. 2016). Here we used the same logic
to increase SUMOylation at consensus sequences in the LP neuron to test if/how this affected I h
Gmax and activity-dependent regulation of Ih.
We cloned lobster SUMO cDNA (GenBank accession: MF770707) and used standard
techniques to generate an N-terminal Tat-tagged SUMO peptide (Supp Fig 4.1). The activated
form of the peptide that ends in a C-terminal di-glycine was created; it required no further
proteolytic processing before addition to a target (See Supp Fig 4.1)(Mukhopadhyay and Dasso
2007). Peptides tagged with an HIV-Tat sequence are rapidly taken up by cells (Fawell, Seery et
al. 1994). After confirming that the activated Tat-SUMO peptide was successfully taken up by
crustacean neurons (Supp Fig 4.1), we tested its effect on LP I h Gmax.
The three standard voltage protocols were used in experiments as diagramed in Fig 4.4A.
A 30min wash-in of activated Tat-SUMO had the opposite effect of blocking SUMOylation; it
produced a stable and significant 11±1.5% increase in the mean LP I h Gmax in the absence of DA
(Fig 4.4B) as opposed to the ~14% decrease produced by anacardic acid blockade (Fig 4.3A).
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The mean τ for the increase was 7.1min. The same result was obtained when the Tat-SUMO
peptide was applied during a 30min -100%ΔDC or 0%ΔDC voltage protocol (Fig 4.4B),
indicating that an activity-independent process transduced enhanced SUMO availability into an
increase in LP Ih Gmax. Note that DA-enabled event 1 produced an activity-independent, ~12%
increase in LP Ih with a time constant of 9.9min (Krenz, Rodgers et al. 2015). Thus, enhancing
SUMO availability in LP mimicked DA-enabled event 1. Enhanced SUMO availability also
occluded DA-enabled event 1. A 30min activated Tat-SUMO wash-in was followed by
application of the -100%ΔDC protocol in the presence or absence of 5nM DA. The data showed
that application of the -100%ΔDC protocol in the presence of DA produced no further change in
LP Ih (Fig 4.4C).
Enhanced activated SUMO availability mimics and occludes DA-enabled event 1. An
increase in activated SUMO ultimately translates into enhanced target protein SUMOylation.
Lobster HCN channels are targets of SUMOylation (Fig 4.2A). HCN channel SUMOylation can
augment HCN channel surface expression (Parker, Welch et al. 2016). Together, these data
suggest that DA-enabled event 1 may represent enhanced HCN channel SUMOylation.
Using the same experimental protocol (Fig 4.4A), we also examined whether or not
enhanced SUMO availability blocked the DA-enabled, calcineurin-mediated, activity-dependent
decrease in LP Ih (event 2). Enhanced SUMO availability did not obviously alter event 2 (Fig
4.4C). In the presence of tonic 5nM DA and limitless activated SUMO, the +50%ΔDC protocol
still produced a significant average 9.5±1.8% decrease in LP Ih Gmax. This decrease was not
observed in the absence of tonic DA. Thus, enhanced SUMO availability did not block the
calcineurin-mediated decrease in LP Ih, and event 2 still required DA’s permissive effect.
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4.4.6

DA blocks the effect of enhanced SUMO availability on LP IA

We previously demonstrated that increasing Kv4.2 channel SUMOylation at an identified
consensus sequence significantly decreased IA Gmax in Hek cells (Welch, Forster et al.). Note that
in Hek cells, increased channel SUMOylation drove G max in opposite directions for IA and Ih. In
order to determine the effect of increased activated SUMO availability on LP I A, experiments
using the three standard voltage protocols were performed as diagramed in Figure 4.5A. In the
absence of Tat-SUMO wash-in, LP peak IA was stable during a 30min 0%ΔDC voltage protocol
(Fig 4.5B). Enhancing the availability of activated SUMO, while keeping duty cycle constant,
mimicked and occluded the decrease in peak IA normally elicited by an increasing LP duty cycle.
A 30min wash-in of activated Tat-SUMO during a 0%ΔDC voltage protocol produced a
significant 10.1±1.4% reduction in the mean peak IA that was stable by 30min (Fig 4.5B). This
was opposite to the ~10% increase produced by blocking SUMOylation with anacardic acid (Fig
4.3A). Additionally, there was no further change in LP peak I A when the +50%ΔDC protocol
was implemented after the 30min wash-in of activated Tat-SUMO (Fig 4.5C). On the other hand,
decreasing duty cycle by implementing the -100%ΔDC protocol after a 30min activated TatSUMO wash-in produced a slightly lower, but still significant, mean 7.6±2.3% increase in peak
IA (Fig 4.5C). Together these data suggest that bi-directional activity-dependent regulation of LP
IA may be similar to Ih in that it involves two events: event 1- An activity-independent process
that increases SUMOylation and event 2- An activity-dependent process that may reduce
SUMOylation.
If enhanced SUMOylation mediates the decrease in LP IA elicited by an increased duty
cycle, and tonic 5nM DA can block the activity-dependent decrease in LP IA (Fig 4.1C), then DA
should block the effect of enhanced activated SUMO availability. In a separate series of

85

experiments, 5nM DA was added to the superfusate 10min prior to the start of the 30min TatSUMO wash-in; otherwise, the experimental protocol was identical. Tonic 5nM DA completely
blocked the decrease in LP IA due to enhanced activated SUMO availability (Fig 4.5B). This
result is consistent with our hypothesis that DA reconfigures the targets of the SUMOylation
machinery to remove activity-dependence from one conductance and bestow it on another.
4.5

Discussion
Neurons exhibit several types of activity-dependent plasticity that act on synaptic

strength and dynamics (Blitz, Foster et al. 2004, Turrigiano 2011, Daur, Bryan et al. 2012),
intrinsic properties (Rodgers, Fu et al. 2011, Krenz, Hooper et al. 2013, Krenz, Rodgers et al.
2015) and even electrical coupling (Lane, Samarth et al. 2016); but, it is unclear how the
plurality of mechanisms is organized to simultaneously effect both change and stability, and how
this organization is restructured with changes in state. We investigated one mechanism of HIM
that promotes stability by maintaining a positive correlation between LP I A and Ih to preserve
neuronal activity phase. Our study showed that activity-dependent SUMOylation specified a
positive correlation between LP IA and Ih, but that modulatory tone played a permissive role in
implementing that correlation. Fig 4.6 summarizes SUMOylation-mediated, activity-dependent
regulation of the two conductances. Alterations in LP duty cycle drove changes in SUMOylation
that modified current amplitudes (Fig 4.6). The activity-dependent changes in SUMOylation
were opposite for the two conductances, but the effect of SUMOylation on current amplitudes
was also opposite; thus, a positive correlation was specified. We initially hypothesized that DA
alone permitted the positive correlation between LP IA and Ih; however, our data proved the
hypothesis wrong. Tonic 5nM DA disabled activity-dependent regulation of LP IA, and thereby
prevented the correlation. The data suggest that the correlation will only be observed when LP is
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bathed by the appropriate modulatory mélange that allows the simultaneous activity-dependent
regulation of both conductances.
We previously demonstrated that DA permitted activity-dependent regulation of LP Ih by
enabling two distinguishable events (Krenz, Rodgers et al. 2015). Event 1 produced an activityindependent increase in Ih Gmax. Here we showed that event 1 was mimicked and occluded by
increasing the availability of activated SUMO in the LP neuron. Furthermore, event 1 could be
blocked by globally inhibiting LP SUMOylation with anacardic acid. Previous experimentation
on Hek cells overexpressing mouse HCN2 channels showed that increasing SUMO availability
enhanced SUMOylation of the HCN channel at a specific consensus sequence, and this resulted
in increased surface expression and augmentation of Ih Gmax (Parker, Welch et al. 2016). Western
blot experiments indicated that lobster HCN channels were SUMOylated in vivo. The most
parsimonious interpretation of these data is that DA-enabled event 1 produces an increase in LP
Ih Gmax by enhancing HCN channel SUMOylation and surface expression. We previously
demonstrated that event 2 produced an activity-dependent, CaM-calcineurin-mediated decrease
in Ih Gmax (Krenz, Rodgers et al. 2015). Here we demonstrated that globally blocking LP
SUMOylation, mimicked and occluded the decrease associated with event 2. One of the most
straight forward interpretations is that event 2 represents a DA-enabled, Ca2+-dependent
reduction in HCN channel SUMOylation and surface expression. In the simplest case, the
combination of DA-enabled events 1 and 2 help to bi-directionally regulate the SUMOylation
profile and surface expression of HCN channels in an activity-dependent fashion.
Activity-dependent regulation of LP IA also appeared to depend on two separable events
that may regulate Kv4 channel SUMOylation. Western blot experiments showed that lobster Kv4
channels, which mediate LP IA (Baro, Levini et al. 1997, Baro, Ayali et al. 2000), were
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SUMOylated in vivo. Blocking SUMOylation mimicked and occluded the activity-dependent
increase in LP peak IA that was observed during the -100%ΔDC protocol. Enhanced activated
SUMO availability produced an activity-independent decrease in LP IA that mimicked and
occluded the reduction observed during the +50%ΔDC voltage protocol. Blocking SUMOylation
prevented the activity-dependent decrease observed during the +50%ΔDC voltage protocol. In
another study on Hek cells, we showed that increased SUMOylation reduced I A mediated by
mouse Kv4.2 channels, and that the decrease was blocked by mutating a specific SUMO
consensus sequence on Kv4.2 (Welch, Forster et al.). It is not yet clear whether the surface
expression and/or biophysical properties of mouse Kv4.2 channels were altered, as
SUMOylation can affect both characteristics (Henley, Craig et al. 2014). In the simplest case, the
data suggest that an activity-independent process (event 1) increases LP Kv4 channel
SUMOyaltion to reduce IA, while an activity-dependent process (event 2) decreases LP Kv4
channel SUMOylation to augment IA. Tonic 5nM DA blocked events 1 and 2.
DA could permit (Ih) and prevent (IA) activity-independent event 1 by reconfiguring the
targets of the SUMOylation machinery. The literature suggests that this could be accomplished
by alterations in target protein phosphorylation states (Hietakangas, Anckar et al. 2006,
Konopacki, Jaafari et al. 2011, Loriol, Casse et al. 2014, Dustrude, Moutal et al. 2016). Target
phosphorylation can either promote or prevent target SUMOylation. For example, one target
protein, cytosolic axonal collapsin response mediator protein 2 (CRMP2), which enhances the
surface expression of NaV1.7 channels, has phosphorylation sites with opposing effects
(Dustrude, Wilson et al. 2013, Dustrude, Moutal et al. 2016). Phosphorylation at S522 by Cdk5
promoted CRMP2 SUMOylation. Conversely, phosphorylation at Y32 by Fyn inhibited CRMP2
SUMOylation. Ultimately, the phosphorylation state of CRMP2 helped determine its
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SUMOylation state and thereby NaV1.7 surface expression. These findings provide a simple
potential mechanism for how modulatory tone could (re)configure the targets of the
SUMOylation machinery.
It is not clear how DA permits/prevents activity-dependent event 2. Activity can regulate
SUMOylation in a cell specific manner. SUMOylation was globally increased by either KCl
depolarization in SHSY5Y cells and hippocampal neurons (Lu, Liu et al. 2009, Lee, Dale et al.
2014) or TTX activity blockade in cortical neurons (Craig, Jaafari et al. 2012). Activitydependent changes in SUMOylation profiles are often mediated by altering the abundance,
location and/or activity of the SUMOylation machinery. The SUMO conjugating enzyme, Ubc9,
is increased both pre- and post-synaptically in response to LTP (Feligioni, Nishimune et al. 2009,
Jaafari, Konopacki et al. 2013). In hippocampal neurons, KCl depolarization localizes Ubc9 to
presynaptic but not postsynaptic densities (Loriol, Khayachi et al. 2013). Increased neuronal
activity and activation of mGluR5 leads to diffusional trapping of Ubc9 in hippocampal dendritic
spines (Loriol, Casse et al. 2014). The N-terminus of the SENP family of SUMO deconjugating
enzymes controls their abundance, localization and activity (Hickey, Wilson et al. 2012, Nayak
and Muller 2014, Mendes, Grou et al. 2016). SENP was decreased by TTX activity blockade in
cortical neurons (Craig, Jaafari et al. 2012). In hippocampal neurons, KCl depolarization led to a
transient presynaptic redistribution of SENP (Loriol, Khayachi et al. 2013). Phosphorylation is
known to regulate both SUMO conjugating and deconjugating enzymes (Baldwin, Julius et al.
2009, Hickey, Wilson et al. 2012, Su, Yang et al. 2012, Lin, Liu et al. 2016), and it is reasonable
to assume that Ca2+-dependent kinases and phosphatases could alter Ubc9 and/or SENP activity,
abundance and localization in the LP neuron to produce activity-dependent deSUMOylation. DA
could influence this pathway through any number of mechanisms.
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Dynamic SUMOylation appears to contribute to baseline LP I A and Ih. Blocking
SUMOylation over the course of 1hr, in the absence of DA while keeping activity constant,
produced a significant decrease in LP Ih Gmax and a significant increase in LP peak IA. This
suggests that ongoing processes of SUMOylation and deSUMOylation dynamically tune LP
ionic conductances and that SUMOylation states may reflect the continuous integration of
chemical signals and electrical activity. Identifying ion channel SUMOylation profiles, their
effects and their regulation could provide insight into how activity correlates multiple
conductances and how modulatory tone permits or prevents those correlations.
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Figure 4.1 Tonic 5nM DA reconfigures the activity-dependence of LP IA and Ih
(A) Experimental Protocol for examining activity-dependence of LP IA. The diagram depicts LP
slow wave activity at t=-10min. Plateau duration (250ms), peak (-40mV) and nadir (-60mV)
voltages, and cycle period (850ms) were measured and used to create the three diagrammed
voltage protocols. Note voltage protocols were always specifically designed for each cell based
on measurements from that cell. The protocols were used in standard experiments as diagramed.
At t=-5min, TTX was bath applied and the 0%∆DC protocol was initiated. At t0 the current was
measured (red asterisk) and one of the two indicated series of voltage protocols was implemented
in the presence or absence of 5nM DA. The current was measured at the end of each protocol as
indicated by the red asterisks. The order of the voltage protocols was varied between
experiments as shown in the two timelines. (B) LP Ih activity-dependence. Data were taken from
(Krenz, Rodgers et al. 2015). The plot represents the percent change in LP Ih Gmax resulting from
a 10min change in duty cycle in the presence or absence of 5nM DA, as indicated. Green
asterisks represent a significant difference within a treatment group using paired t-tests, p<0.05.
Black asterisks indicate significant differences using a One-way ANOVA with Bonferroni’s
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multiple comparisons post hoc tests to compare selected pairs, as indicated, F(3,23)= 9.146;
p=0.0004. (C) LP IA activity-dependence. The plot represents the percent change in LP peak IA
following a 20min change in duty cycle [(t60÷t40 or t20÷t0)-1x100] using the indicated voltage
protocol in the presence or absence of 5nM DA. Green asterisks, significant difference within a
treatment group using paired t-tests (t0 vs t20, or t40 vs t60), p≤0.05. Black asterisks, significant
differences using a One-way ANOVA with Bonferroni’s multiple comparisons post hoc tests to
compare selected pairs, as indicated, F(3,31)= 8.512; p<0.0003
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Figure 4.2 Panulirus interruptus HCN and Kv4 channels are SUMOylated in vivo
Lysates prepared from lobster nervous system tissue were used in immunoprecipitation (IP)
experiments with antibodies against the lobster HCN channel (anti-HCN) (A), the lobster Kv4
channel (anti-ORF-J) (B) or IgG (A and B, negative control). Western blots (WB) containing the
IP products were probed with anti-HCN, anti-ORF-J, or mouse anti-SUMO as indicated.
Immunoprecipitation experiments were repeated with at least three animals for each channel and
representative results are shown. The SUMO modified HCN and Kv4 channels have been
indicated. Asterisks indicate SUMOylated proteins that potentially interact with the
immunoprecipitated channel. Unmarked bands present in the IgG IP represent noise
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Figure 4.3 SUMOylation is necessary for the maintenance and activity-dependence of LP
Ih and IA
(A) SUMOylation contributes to the maintenance of LP I h and IA. Either Ih or IA was measured at
t=0, anacardic acid (AA) was added to the superfusate and the 0%ΔDC protocol was
implemented for 1hr after which the current was re-measured. The mean percent change in each
current is plotted [(t60÷t0)-1x100]. Asterisk, paired t-test p<0.05, n=6 each. (B) The effect of AA
on activity-dependent changes in LP Ih. The experiment was similar to that depicted in Fig 4.1A,
except that AA was added to the superfusate 1hr prior to TTX. Upper panel: Current traces from
two representative experiments are shown. Two current traces elicited by a hyperpolarizing
testpulse to -120mV during a single experiment were overlaid. The two traces from the same cell
represent LP Ih immediately after a 20min -100%∆DC protocol (purple) or a +50%∆DC protocol
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(cyan); scale bars, 10nA and 1s. Lower panel: Plot of the mean percent change in LP I h Gmax
following a 20min change in duty cycle in the presence of AA. Experiments lacking AA are
shown for comparison. Green asterisks significant difference within a treatment group using a
paired t-test, p<0.05. Black asterisk significant difference between the four treatment groups
using a One-way ANOVA with Bonferroni’s multiple comparisons post hoc tests to compare
selected pairs, as indicated, F(3,17)= 7.814; p=0.0017. NS, no significant difference (C) The
effect of AA on activity-dependent changes in LP IA. The experiment was similar to that
depicted in Fig 4.1A, except that AA was added to the superfusate 1hr prior to TTX. Upper
panel: Current traces from two representative experiments are shown. Two current traces elicited
by a depolarizing testpulse to +40mV during a single experiment were overlaid. The two traces
from the same cell represent LP IA immediately after a 20min -100%∆DC protocol (purple) or a
+50%∆DC protocol (cyan); scale bars, 100nA and 40ms. Lower panel: Plot of the mean percent
change in peak LP IA following a 20min change in duty cycle in the presence of AA.
Experiments lacking AA were shown for comparison. Green asterisks, significant difference
within a treatment group using a paired t-test, p<0.05. Black asterisks, significant differences
using a One-way ANOVA with Bonferroni’s multiple comparisons post hoc tests to compare
selected pairs, as indicated, F(3,19)= 11.87; p=0.0001. NS, no significant difference
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Figure 4.4 Enhancing SUMO availability converts DA-enabled, LP Ih activitydependence from bi-directional to uni-directional
(A) Experimental Protocol. The diagram generally depicts the experiments; red asterisks indicate
points where LP Ih was measured; the order of the -100%ΔDC and +50%ΔDC voltage protocols
was varied between experiments; some experiments ended at t30 or t50. (B) Tat-SUMO wash-in
increases LP Ih G max. Activated Tat-SUMO was added to the superfusate and LP Ih was measured
every 10min for 30min. The percent change in LP Ih Gmax at t10, t20, and t30 relative to t0 is
plotted. Asterisks, significantly different using Repeated Measures ANOVAs with Dunnett’s
post-hoc tests that compared each data point to t0. 0%∆DC: F(4,12)= 21.03; p=0.0026, n=5; 100%∆DC: F(5,15)=23.01; p=0.0002, n=6. (C) Enhancing SUMO availability occludes the DAenabled, activity-dependent increase in LP Ih Gmax but does not alter the DA-enabled activitydependent decrease. After a 30min activated Tat-SUMO wash-in, DA was or was not added to
the superfusate containing activated Tat-SUMO, and the indicated voltage protocols were
applied. The percent change in LP Ih Gmax [(t50÷t30 or t90÷t30)-1x100] in the presence and absence
of DA was plotted. Green Asterisks, significant change within a treatment group (t 50 vs t30 or t90
vs t30), paired t-test p<0.01. Black asterisk, significant difference using a One-way ANOVA with
Bonferroni’s multiple comparisons post hoc tests to compare selected pairs, as indicated,
F(3,16)= 7.101; p<0.003
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Figure 4.5 Enhancing SUMO availability converts LP IA activity-dependence from bidirectional to uni-directional
(A) Experimental Protocol. The diagram generally depicts the experiments; red asterisks indicate
points where LP IA was measured; the order of the -100%ΔDC and +50%ΔDC voltage protocols
was varied between experiments; some experiments ended at t30 or t50. (B) Tat-SUMO wash-in
decreases LP peak IA. Percent change in LP peak IA at t10, t20, and t30 relative to t0. Asterisks,
significantly different using Repeated Measures ANOVA with Dunnett’s post-hoc that compared
each data point to t0; 0%∆DC: F(4,12)=0.1682; p=0.7381, n=5; 0%∆DC + Tat-SUMO:
F(10,30)= 13.65; p=0.0011, n=11; 0%∆DC + Tat-SUMO + DA: F(5,15)= 0.3438; p=0.7086,
n=6. (C) Enhancing SUMO availability occludes the activity-dependent decrease in LP peak IA.
Plot of the percent change in LP peak IA [(t50÷t30 or t90÷t30)-1x100] after the indicated change in
duty cycle. Green Asterisks, significant change within a treatment group (t 50 vs t30 or t90 vs t30),
paired t-test p<0.05. Black Asterisks, significant change between groups, student t-test p<0.05
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Figure 4.6 Summary of SUMO-mediated, activity-dependent regulation of LP Ih and IA
The diagram represents a data-driven 3-dimensional sketch of how current amplitude (y-axis)
and ion channel SUMOylation (z-axis) change according to LP duty cycle (x-axis). The blue bar
represents LP Ih in the presence of 5nM DA and the green bar represents LP I A in the absence of
5nM DA. Activity-dependent changes in current amplitude were similar for both currents:
Increasing duty cycle reduced the current. Activity-dependent changes in SUMOylation were
opposite for target proteins associated with IA and Ih: Increasing duty cycle increased vs.
decreased SUMOylation associated with LP IA vs. Ih, respectively. SUMOylation of the target
proteins produced opposite effects on current amplitude: increasing SUMOylation decreased LP
IA and increased LP Ih. We hypothesize that the ion channels mediating LP IA (Kv4) and Ih
(HCN) were the targets of activity-dependent SUMOylation, but this was not shown directly, and
we cannot rule out the idea that the changes in SUMOylation evoked in this study may occur on
unknown targets
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Figure 4.7 Supplemental 1 - Validation for Tat-SUMO experiments
(A) Comparison of lobster SUMO with each of the mouse SUMOs. SUMO was cloned from
spiny lobster nervous system tissue (GenBank accession: MF770707). Aligning the amino acid
sequence showed that Panulirus SUMO shares ~47% identity with mouse SUMO1(Genbank
accession: P63166) and ~67% identity with mouse SUMO2 and 3 (Genbank accession: P61957
and Q9Z172 respectively). Highlighted areas represent regions of conservation. Arrowhead
indicates the site where SUMO is cleaved to generate the mature peptide ending in di-glycine.
(B) Tat-HA-His-SUMO Construct. Active Panulirus SUMO (C-terminal di-glycine) was
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subcloned into a Tat-HA-His vector, which was then used to synthesize a Tat-tagged Panulirus
SUMO peptide. (C) Western blot of recovered Tat-SUMO peptide. Tat-SUMO peptide was
purified using Ni-NTA agarose resin and was eluted from the resin with incrementally increasing
concentrations of imidazole (100mM, 250mM, 500mM, 1M). Purity of Tat-SUMO peptide was
confirmed by western blotting. Eluted fractions were probed with a rabbit polyclonal anti-mouse
SUMO1 antibody (Santa Cruz Biotechnology, sc-9060; used at 1:4000). Strong band at ~25kDa
in 100mM and 250mM fractions represents Tat-SUMO peptide. Note that this experiment also
validates that the mouse anti-SUMO 1 antibody can recognize the lobster peptide. (D) TatSUMO is efficiently taken up by live cells in the STG. Tat-SUMO uptake into STG cells was
tested by bath applying varied concentrations of the peptide to the STG (0nM, 10nM, 100nM,
and 1µM). The preparations were then fixed and immunostained with a validated, commercially
available anti-Tat antibody (Abcam, ab63957, used at 1:200) as previously described (Baro,
Ayali et al. 2000). Tat-SUMO immunostaining was not visible in the absence of bath applied
Tat-SUMO (0nM). When Tat-SUMO was bath applied, immunostaining was clearly visible in
the nucleus and cytoplasm of the neurons as well as in the surrounding glial cells. Tat-SUMO
uptake appeared to increase in a concentration-dependent manner; 100nM appeared to be optimal
with no detectable improvement at a higher concentration. scale bar, 50µm
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Figure 4.8 Supplemental 2 - Validation of antibodies used for immunoprecipitation and
western blotting
(A) An antibody against mouse SUMO 1 recognized lobster SUMO. The lobster and
mouse SUMO proteins are highly conserved and a mouse anti-SUMO 1 antibody is capable of
recognizing a purified recombinant lobster SUMO peptide (Supp Fig 4.1). A western blot
containing lobster nervous system lysate was probed with the same rabbit polyclonal antiSUMO1 antibody. The antibody successfully recognized the ~10kDa free SUMO (arrow) in
addition to other higher molecular weight bands representing other SUMOylated proteins. (B)
The anti-HCN antibody recognized lobster HCN channels expressed in Hek cells. The lobster
HCN channel was subcloned into a GFP expression vector and a GFP-HCN fusion protein was
stably expressed in Hek cells using previously described methods (Parker, Welch et al. 2016).
The GFP-HCN channel was isolated from Hek cell lysates in IP experiments using an antibody
against GFP. Western blots containing the IP product were probed with anti-HCN (see materials
and methods). The strong signal visible at ~110kDa represents the channel (arrow). As a
negative control, the IP-western blot experiment was repeated with parental Hek cells that did
not express the GFP-HCN construct. (C) The anti-ORF-J antibody recognized the lobster Kv4
channel in lobster nervous system lysates. Western blots containing lobster nervous system
protein lysates were probed with anti-ORF-J or anti-shal, a previously validated antibody against
the lobster Kv4 channel (Baro, Ayali et al. 2000). Both antibodies recognized the same ~75kDa
band (arrow)
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Table 4.1 Lobster SUMO Primers
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5
5.1

GENERAL DISCUSSION

SUMO regulation of neuronal homeostasis
The work presented here demonstrates that within a single neuron, SUMO can

orchestrate the activity-dependent regulation of multiple ionic conductances. This speaks to a
much larger potential role for SUMOylation in coregulating activity-dependent mechanisms
involved in the maintenance of neuronal homeostasis. Recent studies have found linked changes
in neuronal SUMOylation with changes in neuronal excitability. In hippocampal neurons for
example, including SUMO in a patch pipette increases neuronal excitability, with the inverse
being true when the deSUMOylating enzyme, SENP, was included in the pipette (Plant, Dowdell
et al. 2011). Altering neuronal excitability can also impact the SUMOylation machinery and
consequently, SUMOylation of target proteins. Suppression of activity with TTX results in a
global decrease in SENP and therefore an increase in SUMOylated proteins (Craig, Jaafari et al.
2012). Depolarizing hippocampal neurons with KCl reorganizes the SUMOylation machinery
and SUMOylated proteins at pre- and postsynaptic sites (Loriol, Khayachi et al. 2013). With
global changes in SUMOylation affecting neuronal excitably, and SUMOylation being under the
influence of changes in neuronal excitability it is not a stretch to infer that SUMO may be
important for some types of activity-dependent regulation. Our work further supports this idea by
showing that SUMOylation mediates the correlated activity-dependent regulation of two ionic
conductances whose coregulation is known to be important for homeostasis of network activity.
This study has shown that under the appropriate modulatory tone, SUMO can mediate
activity-dependent regulation of two ionic conductances within a single neuron. There have been
many studies examining what SUMO is doing in hippocampal neurons, and when assembled
they illustrate a complex system of regulation. For example, SUMO regulates multiple glutamate
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receptors in distinct ways in hippocampal neurons. SUMOylation of the metabotropic glutamate
receptor subunit, mGluR7, stabilizes the receptor in the cell membrane (Choi, Park et al. 2016).
The ionotropic glutamate receptor subunit, GluK2, is SUMOylated following phosphorylation of
the receptor and results in increased internalization of GluK2 containing receptors (Chamberlain,
Gonzalez-Gonzalez et al. 2012). Kainate binding promotes SUMOylation of GluR6 containing
receptors and their subsequent internalization (Martin, Nishimune et al. 2007). Specific K+
channels were also identified as SUMO substrates in hippocampal neurons. For example,
SUMOylation of the Kv2.1 channel positively shifts its voltage of half activation (Plant, Dowdell
et al. 2011), and SUMOylation of the Kv7 channel diminishes the M current leading to
hyperexcitability (Qi, Wang et al. 2014). Direct SUMOylation of each of these channels and
receptor subunits and all of the diverse outcomes are occurring in a single neuronal cell type. Is
SUMO simultaneously regulating all of these processes? The evidence presented here and the
work of other investigators suggest that there may be mechanisms, like tonic DA modulation and
phosphorylation, which can promote or prevent SUMO regulation of specific targets within a
single cell (Dustrude, Wilson et al. 2013, Dustrude, Moutal et al. 2016).
5.2

The function of tonic DA
DA can be present in two functionally distinct concentrations (tonic and phasic). Phasic

DA corresponds to a transient increase in DA concentrations (µM-mM) resulting from burst
firing of dopaminergic neurons. Phasic DA functions to encode reward signals and can promote
the later phase of plasticity in the prefrontal cortex, hippocampus, and striatum (Frey, Matthies et
al. 1991, Grace 1991, Gurden, Tassin et al. 1999, Gurden, Takita et al. 2000, Reynolds, Hyland
et al. 2001, Floresco, West et al. 2003, Huang, Simpson et al. 2004). Tonic DA refers to low
steady-state concentrations of DA (nM) produced by the slow single spike activity of DA
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neurons (Grace 1991, Keefe, Zigmond et al. 1993, Goto, Otani et al. 2007). Although less is
known about the function of tonic DA, the consensus is that dopaminergic tone stabilizes neural
network activity or maintains a specific neuronal activity state (Durstewitz, Seamans et al. 2000,
Durstewitz, Seamans et al. 2000, Durstewitz and Seamans 2002, Bilder, Volavka et al. 2004,
Matsuda, Marzo et al. 2006, Sikstrom and Soderlund 2007, Kroener, Chandler et al. 2009). Our
work has begun to characterize the mechanisms through which tonic DA can act to stabilize
neuronal activity states.
5.2.1

Tonic spiking of DA neurons

One important question to address first is, why do DA neurons fire tonically? Is it solely
to maintain a specific level of extracellular dopaminergic tone, or is there more to the story? DA
neurons fire tonically due to the presence of pacemaker channels (Grace and Bunney 1983), and
this firing can be up and down-regulated based on afferent glutamatergic or GABAergic input
(Grace and Bunney 1984, van Zessen, Phillips et al. 2012, Chang and Grace 2014). Within a
given population of DA neurons, only a fraction is tonically active. Tonic spiking of DA neurons
doesn’t just establish the nM levels of extracellular DA, but it provides a pool of neurons that can
respond to phasic stimulation (Floresco, West et al. 2003, Lodge and Grace 2006, Belujon and
Grace 2015, Grace 2016). Only DA neurons that are tonically active can respond to a stimulus
with phasic bursting activity. Therefore, increasing or decreasing the number of tonically firing
DA neurons will up or downregulate, the magnitude of the phasic response. This means that the
tonic activity of DA neurons themselves functions to modulate the extent of the system’s phasic
response. Therefore, neurons providing afferent inputs on DA neurons (ventral pallidum,
pedunculopontine tegmental nucleus) can contextualize phasic stimulation by modulating the
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number of tonically active neurons (Blaha, Yang et al. 1997, Lokwan, Overton et al. 1999,
Floresco, Todd et al. 2001, Lodge and Grace 2006).
5.2.2

Dopaminergic tone stabilizes neuronal activity states

The stabilizing effect of tonic DA is thought to be mediated by the nM levels of DA
present in the extracellular space rather than the tonic spiking activity of the DA neurons
themselves. There are two different schools of thought on how tonic nM levels of DA can
stabilize neuronal activity states, and it is likely that both mechanisms exist in vivo, either
simultaneously or under contextually different circumstances. The first model suggests that tonic
DA acts through either autoreceptors or desensitization of DA receptors to “set the gain” for the
phasic response, thus maintaining stable neuronal activity (Belujon and Grace 2015, Grace
2016). There are multiple theories about how this function is accomplished. Some investigators
have said that tonic DA can set the threshold needed for phasic activity to alter an activity state.
This would permit the maintenance of an activity state while still allowing a degree of flexibility
if the phasic response can exceed that threshold (Durstewitz, Seamans et al. 2000, Durstewitz,
Seamans et al. 2000, Durstewitz and Seamans 2002, Bilder, Volavka et al. 2004). Other
investigators have demonstrated that tonic DA acting on autoreceptors can determine the
magnitude of the phasic response. When tonic DA levels are enhanced the magnitude of phasic
release is reduced, and conversely, a decrease in dopaminergic tone will enhance phasic release
(Grace 2000, Floresco, West et al. 2003, Bilder, Volavka et al. 2004, Sikstrom and Soderlund
2007). Tonic DA levels have also been shown to have a desensitizing effect on DA receptors,
with agonist binding leading to internalization of DA receptors (Grace 1991, Grace 2000).
However, it is worth noting that different responses have been observed in heterologous
expression systems versus slice cultures. Even between heterologous expression systems, the
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mechanisms mediating DA receptor internalization appear to differ in some respects (Ito, Haga et
al. 1999, Kim, Valenzano et al. 2001, Celver, Sharma et al. 2013, Robinson, Bunzow et al.
2017).
The second prevailing theory proposes that tonic DA, acting at high-affinity DA
receptors, stabilizes neuronal activity by regulating ionic conductances and certain types of
plasticity. In the crustacean STG, many studies have shown that conductance correlations
maintain specific neuronal activity features (Temporal, Desai et al. 2012, Zhao and Golowasch
2012, O'Leary, Williams et al. 2013, Temporal, Lett et al. 2014, Marder, Goeritz et al. 2015).
Specifically, DA has been shown to play an important role in the maintenance of conductance
correlations (Khorkova and Golowasch 2007, Krenz, Parker et al. 2015). In LP, the correlation of
IA and Ih is important to maintain LP timing within the circuit (MacLean, Zhang et al. 2003).
When the ratio of IA to Ih is disrupted, LP activity phase is altered and in the presence but not the
absence of tonic nM DA, and LP activity phase is restored (Rodgers, Fu et al. 2011, Krenz,
Hooper et al. 2013, Krenz, Rodgers et al. 2015). Tonic DA mediates LP phase recovery by
permitting activity-dependent regulation of Ih that restored the correlation between LP IA and Ih
(Krenz, Rodgers et al. 2015). The work that was presented in this study further illuminated the
mechanism through which tonic DA acts to stabilize activity. Tonic DA can select the ionic
conductance target for activity-dependent regulation by SUMO.
In addition to regulating ionic conductances to maintain a stable rhythmically active
network, studies using rodent models have also described a role for tonic DA in the regulation of
synaptic plasticity. Recent behavioral research in mice has shown that tonic DA is important for
preserving and maintaining a learned association (Ellwood, Patel et al. 2017). In this study,
optogenetic stimulation was used to drive either tonic or phasic firing of DA neurons while
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examining the function of each in a task that requires the mice to learn a specific association and
then switch to a new association. The researchers found that phasic DA mediated the learning of
new associations while tonic DA preserved the previously learned association, hindering the
learning of a new one (Ellwood, Patel et al. 2017). While this behavior based study does not yet
speak to a specific mechanism, it highlights the importance of tonic DA maintaining a learned
plasticity state. Research in the rat prefrontal cortex has found that tonic DA is needed for the
appropriate induction of LTP. In the presence of “normal” physiological levels of tonic DA,
high-frequency stimulation induces LTP (Matsuda, Marzo et al. 2006). However, through the use
of either DA agonist/antagonist or PFC slice cultures that are absent of dopaminergic tone,
researchers have discovered phasic DA can trigger either LTD or LTP in the prefrontal cortex
depending on the level of dopaminergic tone (Otani, Bai et al. 2015). Phasic DA stimulation in
the presence of low/no or elevated tonic DA induces LTD (Otani, Blond et al. 1998, Otani,
Auclair et al. 1999); conversely, phasic DA stimulation in the presence of physiological levels of
tonic DA induces LTP (Matsuda, Marzo et al. 2006). Taken together, these studies illustrate
diverse roles for tonic DA that may vary based on cell type and cellular context.
5.2.3

Dysfunctions associated with dopaminergic tone

Understanding disease states that are associated with alterations in dopaminergic tone can
provide valuable insight into its behavioral and physiological functions. This is not always an
easy task, however, because many dysfunctions that result from alterations in the DA system
may affect both tonic and phasic DA. Yet, researchers are making efforts to distinguish between
the two, because understanding whether certain symptoms result from alterations in
dopaminergic tone versus phasic DA release can better inform what treatments may be most
effective. For example, in Parkinson’s Disease, a majority of the symptoms associated with the
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disease (resting tremors, rigidity, and bradykinesia) result from the loss of dopaminergic neurons
in the substantia nigra (Hammond, Bergman et al. 2007). This would mean that dopaminergic
tone would be significantly depleted. Researchers have linked this decrease in tonic DA to a
significant down-regulation in HCN channel expression in globus pallidus neurons, leading to
the motor dysfunction associated with Parkinson’s Disease (Chan, Glajch et al. 2011). These
findings are particularly relevant to the work presented here because we have also shown that
tonic DA plays a significant role in both short-term and long-term regulation of Ih (Rodgers, Fu
et al. 2011, Krenz, Hooper et al. 2013, Krenz, Parker et al. 2014, Krenz, Rodgers et al. 2015).
Disruption in tonic DA has also been suggested to play an important role in Attention
Deficit Hyperactivity Disorder (ADHD). Recent studies have shown that in human subjects
diagnosed with ADHD tonic DA in the right caudate was significantly reduced, whereas phasic
DA release in the right caudate was significantly increased (Sikstrom and Soderlund 2007,
Badgaiyan, Sinha et al. 2015). These results are consistent with the attentional deficits associated
with ADHD because the right caudate is known to control executive inhibition and selective
attention, and dysfunctional regulation of this region could lead to attentional deficits. Substance
addiction is also correlated to alterations in tonic DA. Specifically, it has been shown that
repeated drug administration increases tonic DA, consequently decreasing the phasic response
(Grace 2000). This subdued phasic response would increase drug-seeking behavior because
stronger doses would be needed to elicit the desired phasic response, further increasing the
dopaminergic tone in a vicious cycle. Lastly, Schizophrenia is associated with hyperresponsiveness of the dopaminergic system (Grace 1991, Durstewitz and Seamans 2008, Grace
2016). The evidence indicates that this hyperdopaminergic state results from hyperactivity of the
hippocampus, which supplies excitatory afferent stimulation to VTA dopaminergic neurons
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(Heckers 2001, Medoff, Holcomb et al. 2001, Grace 2016). This leads to an increase in tonically
active DA neurons and thereby an enhanced phasic response. It is clear that dysregulation of the
dopamine system has far reaching implication, and it has become more apparent over time that to
fully understand these disease states we must examine the distinct role of both tonic and phasic
DA and how the two intersect.
5.3

Limitations of Exogenous Expression and Heterologous Expression Systems
With any form of research, it is important to understand the limitations of your chosen

system and experimental techniques. A significant portion of the research presented here utilizes
Hek cells as a heterologous expression system to stably express the HCN channel, which can
then be used to study the effects of SUMOylation on the channel. Hek cells are widely used for
studies investigating protein-protein interactions because they divide quickly and are easily
transfected and cultured in a laboratory setting. However, stable expression of a protein requires
the gene for the new protein be integrated into the Hek cell genome, and there is no way to
control the number of copies that have been integrated into the genome. This means that when
comparing across separate stable cell lines, for example, cell lines expressing the wild-type
protein versus a mutated form of the protein, each cell line could have a different copy number.
In our study, we look at SUMO modification of HCN channels stably expressed in Hek cells.
Therefore, if a particular cell line expresses the channel at a significantly higher level, the
endogenous SUMOylation machinery may not be able to maintain the baseline (control) level of
SUMOylated HCN channels at a level that is consistent with the other cells lines with lower
HCN channel expression. These types of differences are important to consider when interpreting
your findings using a heterologous expression system.
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Researchers also commonly use exogenous expression of a protein or gene of interest to
study its effects. For example, in our study we transfected SUMO and Ubc9 to overexpress those
proteins in Hek cells. We also used Tat-SUMO to exogenously increase SUMOylation in the
STG neurons. Four our research, these techniques provide valuable information about the effects
SUMOylation on a specific channel or ionic current, but these findings should also be considered
in a biological context. Is increasing SUMOylation to the maximum level that the endogenous
enzymes can accommodate producing a change that could be observed under normal biological
conditions? For this reason, it is important also to consider including experiments that examine
changes that occur through endogenous mechanisms and then the effect of the response to
exogenous expression can be compared to the endogenous response.
5.4

Conclusions
This dissertation has provided evidence of a novel regulatory role for SUMOylation in

the coregulation of IA and Ih. This finding is significant because, conductance correlations play
an important part in neuronal homeostasis, and this study can further illuminate the mechanisms
that mediate rapid homeostatic coregulation of ionic conductances because they are as of yet not
well understood. This work has also demonstrated a mechanism by which tonic DA can select
ionic conductance targets for activity-dependent regulation by SUMO. This is an important
finding because researchers are only just beginning to investigate the specific mechanisms that
underlie tonic DA regulation of neural network activity. Until now there has been no evidence
that modulatory tone is involved in SUMO regulation of ionic conductances. Therefore, this
study has provided a new line of investigation that can have far-reaching implication in the study
of neuronal homeostasis, tonic DA regulation of neuronal activity, and SUMO regulation of
ionic conductances in vertebrates as well as invertebrates.
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